Mastercard zveřejní výsledky za 2. čtvrtletí před otevřením trhu ve čtvrtek 30. července. Analytici čekají zisk 4,78 USD na akcii a tržby 9,08 miliardy USD.
Mastercard Incorporated (NYSE:MA) will release its second quarter earnings report before the opening bell on Thursday, July 30.
Analysts expect the Purchase, New York-based company to report quarterly earnings of $4.78 per share, up from $4.15 per share in the year-ago period. The consensus estimate for Mastercard’s quarterly revenue is $9.08 billion. It reported $8.13 billion last year, according to Benzinga Pro.
On July 2, VEON announced a collaboration with Mastercard to expand financial services across Ukraine, Kazakhstan, Pakistan and Uzbekistan.
Shares of Mastercard rose 0.1% to close at $563.32 on Wednesday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.
Considering buying MA stock? Here’s what analysts think:
Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs
Komerční banka ve 2. čtvrtletí snížila čistý zisk na 4,51 mld. Kč, ale překonala odhad a navrhuje dividendu ve výši 80 % konsolidovaného čistého zisku.
Komerční banka ve druhém čtvrtletí doručila nižší čistý zisk, ale navýšila provozní výnosy i čistý úrokový výnos. Vedení zůstává optimistické a očekává další růst úvěrů i vkladů v návaznosti na oživení české ekonomiky.
Komerční bance ve druhém kvartálu vzrostl čistý úrokový výnos na 6,5 mld. Kč v souladu s odhadem Patrie (vs 6,40 mld. Kč loni). Čisté výnosy z poplatků vzrostly na 1,8 mld. Kč (odhad Patrie 1,69 mld. Kč) z loňských 1,65 mld. Kč. Čistý zisk náležející akcionářům meziročně klesl na 4,51 mld. Kč (odhad Patrie 4,39 mld. Kč) z loňských 4,64 mld. Kč.
Čisté provozní výnosy narostly na 9,36 mld. Kč (odhad Patrie 9,33 mld. Kč) z loňských 9,04 mld. Kč. Provozní náklady v podstatě meziročně stagnovaly na 4,10 mld. Kč (odhad Patrie 4,02 mld. Kč). Náklady na riziko klesly na 39 mil. Kč (odhad Patrie 115 mil. Kč) proti loňským 529 mil. Kč. Provozní zisk tak skončil meziročně výše na 5,26 mld. Kč (odhad Patrie) proti loňským 4,91 mld. Kč.
"Výborné obchodní výsledky se pozitivně promítly do výnosů banky, ale silná konkurence na úvěrovém i depozitním trhu omezovala zejména růst úrokových výnosů," uvedl generální ředitel Komerční banky Jan Juchelka.
Komerční banka očekává, že v roce 2026 poroste česká ekonomika zhruba o 2,1 %, což by mělo podpořit další růst úvěrů i vkladů. Cílí tak na vyšší jednociferný růst úvěrového portfolia i klientských depozit, střední jednociferný růst výnosů a stabilní náklady, zatímco náklady na riziko by měly zůstat velmi nízké kolem 10 bazických bodů. Díky pokračující digitalizaci (KB+), příznivému vývoji v retailovém i korporátním bankovnictví a ukončení mimořádné daně z neočekávaných zisků chce KB v roce 2026 dosáhnout návratnosti vlastního kapitálu (ROE) 13 až 14 % a poměru nákladů k výnosům 44 až 45 %, přičemž plánuje navrhnout dividendu ve výši 80 % konsolidovaného čistého zisku.
Tagy: výsledky, akcie, Komerční banka
Reklama
Na tomto místě můžete zahájit diskusi. Zatím nebyl zadán žádný názor. Do diskuse mohou přispívat pouze přihlášení uživatelé (Přihlásit). Pokud nemáte účet, na který byste se mohli přihlásit, registrujte se zde.
Aktuální komentáře
30.07.2026 8:51I přes pokles čistého zisku Komerční banka překonala odhady a dividenda má dosáhnout 80 % zisku 8:41Erste překonala odhady a zvýšila výhled. Do roku 2030 chce více než zdvojnásobit zisk na akcii 29.07.2026 23:07Meta po výsledcích padá o 8 %, Microsoft těží ze silného růstu Azure 22:15Fed ponechává sazby beze změny ale šířící se disent avizuje růst v září 22:01Akcie po rozhodnutí Fedu kolísaly, růst cen ropy zvýšil nervozitu trhu 17:03Umělá inteligence, nebo budovatelský boom v Číně: Kolik by to vlastně mělo vynášet? 15:14Balistické rakety mění podobu válek. Nové zbrojní závody otevírají příležitosti i pro obranný průmysl 14:48De Beers za zlomek původní hodnoty. Anglo American jedná o prodeji diamantového impéria 13:32SK Hynix roste rekordním tempem, ale trhu to nestačí. AI lídr doplatil na přehnaná očekávání 12:37Klid na Blízkém východě skončil a SK Hynix nepřesvědčil. Čeká se na Fed a velký tech 11:23Morgan Stanley radí vsadit na kombinaci kvality a dividendy 9:33Rozbřesk: Rozhodnutí Fedu v mlze, aneb dokáže Warsh zpacifikovat ostatní, aby sazby nezvedli? 8:49Erste výrazně zvyšuje ambice, Íránský konflikt se znovu vyhrotil a SK Hynix zklamal 6:04Je Musk zodpovědný vůči AI, ale hovoří nezodpovědné nesmysly o Evropě? 28.07.2026 22:00AI akcie zažily další výplach, ale zbytek Wall Street mírně rostl 17:08V Číně už roky probíhá to, čeho se trhy obávají v USA 15:28Citadel jde proti trhu. Zvýšení sazeb očekává už tuto středu 14:29Coca-Cola překonala očekávání a zlepšila výhled. Tahounem jsou nápoje bez cukru i fotbalový šampionát 14:26Boeing sice dál zůstává ve ztrátě, ale návrat k pozitivnímu cash flow potěšil investory 14:01Čínský průlom vyděsil investory. Akcie ASML se propadly, její konkurenční postavení zůstává
Reklama
Související komentáře
Nejčtenější zprávy dne
Nejčtenější zprávy týdne
Nejdiskutovanější zprávy týdne
Kalendář událostí
ČasUdálost 9:00CZ - HDP, q/q 10:00DE - HDP, q/q 11:00EMU - HDP, q/q 13:00UK - Jednání BoE, základní sazba 14:00DE - Harmonizovaný CPI, y/y 14:30USA - Nové žádosti o dávky v nezam. 14:30USA - Výdaje na osobní spotřebu, m/m
Merck a Wellcome prostřednictvím Hilleman Laboratories začnou vyrábět dávky experimentální vakcíny proti ebole Bundibugyo pro rané klinické zkoušky. Projekt podporuje CEPI až 8,5 milionu USD.
Item 1 of 2 A vial and syringe are seen in front of Merck logo in this illustration taken March 26, 2025. REUTERS/Dado Ruvic/Illustration/File Photo
[1/2]A vial and syringe are seen in front of Merck logo in this illustration taken March 26, 2025. REUTERS/Dado Ruvic/Illustration/File Photo Purchase Licensing Rights, opens new tab
SummaryCompaniesCEPI backs effort with up to $8.5 million in fundingHilleman aims to make finished doses for early-stage trials using IAVI starting materialPartners would transfer technology to a large-scale manufacturer if early trials succeedOther vaccine candidates also being fundedCHICAGO, July 30 (Reuters) - Hilleman Laboratories, a Singapore-based joint venture between Merck (MRK.N), opens new tab and the global charity Wellcome, is gearing up to manufacture doses of a promising experimental vaccine against the rare Bundibugyo strain of Ebola responsible for a fast-spreading outbreak in the Democratic Republic of Congo.
The effort is backed by up to $8.5 million in funding from the global partnership Coalition for Epidemic Preparedness Innovations, or CEPI, those involved in the effort said on Thursday.
Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
"With Bundibugyo virus cases rising at worrying speed, the epidemic is fast becoming a humanitarian crisis,” CEPI Chief Executive Richard Hatchett said in a statement.
“No vaccine is currently approved against the virus, so we are urgently advancing vaccine candidates into testing," he said.
As of July 29, the outbreak in the eastern Congo has infected 3,360 people and killed 1,487. There are also no approved treatments for Bundibugyo Ebola.
CEPI has said it is investing up to $8.6 million for the development of a separate Bundibugyo vaccine candidate from the University of Oxford, which began a first human trial earlier this month.
The vaccine is based on ChAdOx1 technology, which was used in the Oxford/AstraZeneca (AZN.L), opens new tab COVID-19 vaccine, and is being manufactured by the Serum Institute of India.
CEPI also committed up to $50 million to develop a Bundibugyo Ebola vaccine with Moderna (MRNA.O), opens new tab.
The Merck/Wellcome collaboration will advance manufacturing of a single-dose vaccine developed by the International AIDS Vaccine Initiative, which the World Health Organization in May singled out as the most promising candidate.
The vaccine uses the same recombinant vesicular stomatitis virus, or rVSV, platform used by Merck for its approved Ervebo Ebola vaccine that targets the more common Zaire strain.
Hilleman will use starting material generated by IAVI to create finished doses that can be used in early-stage trials. Merck will serve as a technical adviser and contribute scientific and manufacturing expertise on the rVSV platform, the company said.
Doses could be ready for clinical testing by the end of this year, Tarit Mukhopadhyay, Merck's head of infectious disease and vaccines discovery, said in an interview.
Merck and CEPI earlier this year partnered on a $30 million program to update the manufacturing processes of Ervebo aimed at improving affordability and access for low- and middle-income countries by increasing yield and extending its shelf life.
Hilleman Labs is equipped to make tens of thousands of doses, which should be plenty of supply for testing, Mukhopadhyay said. Should larger-scale production be needed, the partners have agreed to transfer the vaccine technology to a larger-scale manufacturer.
"None of those plans have been solidified," Mukhopadhyay said.
“We urgently need to strengthen our toolkit against Bundibugyo. The outbreak is in a region faced with conflict, instability, and strained resources, making a holistic response essential,” said Charlie Weller, head of vaccines at Wellcome.
Beyond vaccine testing, treatment trials are underway testing Mapp Biopharmaceuticals' pan-Ebola virus antibody drug called MBP134, and Gilead Sciences' (GILD.O), opens new tab antiviral remdesivir, alone and in combination.
The WHO is also considering trials of Regeneron's (REGN.O), opens new tab antibody drug maftivimab in combination with two other antibodies, and Gilead's oral antiviral drug obeldesivir.
Reporting by Julie Steenhuysen in Chicago; Editing by Bill Berkrot
Our Standards: The Thomson Reuters Trust Principles., opens new tab
MGM Resorts oznámila rekordní konsolidované čisté tržby za 2. čtvrtletí a 20% meziroční růst tržeb MGM Digital. Představenstvo zároveň dál posuzuje nabídku od People Incorporated.
MGM Buyout: The House Doesn't Always WinMGM Resorts International NYSE: MGM said its second-quarter momentum was supported by record consolidated net revenue, continued growth at its Las Vegas Strip properties, record same-store regional revenue and 20% year-over-year revenue growth at MGM Digital.
Chief Executive Officer and President Bill Hornbuckle said the company’s board continues to evaluate an offer from People Incorporated through a special committee of independent directors. Hornbuckle said he and Chief Financial Officer Jonathan Halkyard would not address the proposal during the question-and-answer session.
Get MGM alerts:
Caesars Surges on Buyout Buzz. Should Investors Take the Bet?Hornbuckle said the company entered the second half with positive momentum across Las Vegas, regional casinos, Macau and digital operations, while construction of its Osaka integrated resort remains on schedule for a fall 2030 opening.
Las Vegas revenue and group business supported results In Las Vegas, MGM reported year-over-year growth in both net revenue and segment adjusted EBITDA during the second quarter. Halkyard said Strip-resort EBITDA was up $25 million year to date, primarily reflecting a recovery at MGM Grand following room renovations and a favorable hold benefit.
3 Bargain Stocks the Market Is Sleeping on Right NowGroup and convention business accounted for 20% of MGM’s room mix during the quarter, keeping the company on pace for that segment to represent 20% of full-year room mix, Hornbuckle said. Technology and hospitality corporate groups, business-to-business trade shows and professional association meetings helped drive the company’s highest second-quarter convention average daily rate, as well as record catering and banquet revenue.
Hornbuckle said April and May were strong, with May benefiting from events and other activity. June was more challenging as summer conditions intensified, though July had been favorable. MGM expects a solid third quarter supported by group business and a larger citywide event calendar, while Hornbuckle said the company has “some work to do” in the fourth quarter.
Chief Operating Officer Ayesha Molino said luxury properties and the group segment remained strong, while the lower end of MGM’s Las Vegas portfolio, particularly Luxor and Excalibur, remained challenged but had stabilized.
MGM’s all-inclusive offering at Luxor and Excalibur has booked more than 30,000 room nights since its launch four months ago, according to Hornbuckle. Nearly half of guests booking the offer were first-time MGM visitors. Molino said the package has supported occupancy, generated higher weekend rates, and delivered a favorable margin profile.
The company is also seeking to draw more local customers to Park MGM through food-and-beverage, parking and free-play offers. Molino cited the resort’s proximity to T-Mobile Arena and Dolby Live, its nonsmoking positioning and its existing local high-end gaming business as factors supporting that effort.
Luxury investment plans remain within current capital framework MGM plans further upgrades to its Las Vegas luxury offerings, including work at Bellagio’s convention and public spaces, potential additional villas, and future room renovations at Aria and The Cosmopolitan. Hornbuckle said the company also sees opportunities to build on the activation of Bellagio’s Lakeside area.
Halkyard said MGM can complete significant renovations within the level of capital expenditures it has maintained over the past several years. Projects that expand the company’s physical footprint or add capacity would likely require capital spending above that base level.
“Las Vegas is our home,” Hornbuckle said, describing the market as the epicenter of gaming and saying MGM intends to continue investing in luxury experiences where returns justify it.
MGM is also preparing to host the Players Era Basketball Tournament in November across Mandalay Bay’s Michelob Ultra Arena and T-Mobile Arena. The tournament will include 24 collegiate basketball programs and will be televised on ESPN networks.
Regional casinos set same-store records MGM’s regional operations produced their best quarterly revenue on a same-store basis, with same-store slot handle rising 4% and slot win increasing 3%, Halkyard said. Several properties posted record revenue during the period, including Empire City, which increased gross gaming revenue in June despite new competition in New York state.
Borgata was a major contributor to record same-store casino revenue and slot win, supported by improvements to high-limit gaming areas. MGM plans to enhance premium lounges at Beau Rivage and Borgata and begin room renovations at Borgata before year-end.
Hornbuckle also pointed to the planned Sphere venue near MGM National Harbor as a potential demand driver. He said projections call for approximately 2.5 million visitors at the roughly 6,500-seat venue and that MGM expects to capture demand given its location next to the property.
Macau volumes recovered following World Cup disruption MGM China maintained a 16.4% market share in the second quarter, up one percentage point sequentially. While Macau volumes declined during June amid World Cup activity, company executives said the weakness was temporary.
Kenneth Feng, CEO of MGM China Holdings, said business volumes and visitation improved beginning in the second week of July. He said Macau gaming revenue had recovered to nearly first-quarter levels in the prior week, while MGM’s property visitation and normalized gross gaming revenue had exceeded first-quarter levels.
Feng said MGM’s strategy in Macau centers on optimizing the yield of its gaming floors through a combination of products, service, innovation and promotions rather than promotions alone. The company recently completed suite conversions and expanded premium gaming space at MGM Cotai, and it has begun design work for about 100 suites at MGM Macau.
Digital operations grow as Osaka construction advances MGM Digital generated 20% revenue growth in the quarter and recorded segment adjusted EBITDA losses of $31 million. Halkyard said the company expects MGM Digital’s full-year EBITDA loss to be lower than last year’s as it calibrates its Brazil operations.
Gary Fritz, chief commercial officer and president of MGM Digital, said MGM’s European LeoVegas and BetMGM-branded businesses are positioned for operating leverage and potentially substantial profitability in 2027. MGM expects those operations to help fund some future growth investments, particularly in Brazil.
At the BetMGM North America venture, MGM said iGaming revenue grew 8% in the second quarter. During the first half, handle per active customer rose 7% and net gaming revenue per active customer increased 9% in iGaming. In online sports betting, handle per active customer increased 18% and net gaming revenue per active customer rose 17%.
In Japan, MGM expects its Osaka funding commitment for the second half of 2026 to be approximately $125 million to $175 million. The company has spent about $600 million to date and expects to deploy roughly $1 billion in each of 2027 and 2028, completing its capital commitments. More than 60% of foundation piles have been completed, and MGM said the project remains on time and on budget.
During the quarter, MGM repurchased about 4.3 million shares for $164 million. Halkyard said the company has reduced its share count by nearly 50% over the past five years.
About MGM Resorts International (NYSE:MGM)MGM Resorts International is a leading global hospitality and entertainment company that develops, owns and operates destination resorts, hotels and casinos. Its properties feature integrated gaming floors alongside luxury accommodations, fine dining and retail outlets, live entertainment venues and convention facilities. The company also offers loyalty programs, sports betting and digital gaming experiences to enhance guest engagement and drive repeat visitation.
The company traces its heritage to the opening of the original MGM Grand Hotel & Casino on the Las Vegas Strip in 1973.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in MGM Resorts International Right Now?Before you consider MGM Resorts International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MGM Resorts International wasn't on the list.
While MGM Resorts International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Skyworks Solutions zahájila předobchodní fázi níže poté, co JPMorgan snížila cílovou cenu z 70 USD na 65 USD a ponechala neutrální doporučení. Akcie otevřely na 58,59 USD oproti předchozímu závěru 64,68 USD.
Skyworks Solutions, Inc. (NASDAQ:SWKS – Get Free Report) gapped down prior to trading on Wednesday after JPMorgan Chase & Co. lowered their price target on the stock from $70.00 to $65.00. The stock had previously closed at $64.68, but opened at $58.59. JPMorgan Chase & Co. currently has a neutral rating on the stock. Skyworks Solutions shares last traded at $60.0940, with a volume of 2,453,515 shares.
Other analysts have also recently issued reports about the company. KeyCorp cut Skyworks Solutions from an “overweight” rating to a “sector weight” rating in a research report on Tuesday, July 14th. UBS Group increased their target price on Skyworks Solutions from $65.00 to $70.00 and gave the stock a “neutral” rating in a research report on Wednesday. Mizuho lowered their target price on Skyworks Solutions from $55.00 to $52.00 and set an “underperform” rating for the company in a research note on Wednesday. Craig Hallum raised their target price on Skyworks Solutions from $75.00 to $85.00 in a research note on Wednesday, May 6th. Finally, BNP Paribas Exane lifted their price target on Skyworks Solutions from $60.00 to $70.00 in a research report on Wednesday, May 6th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, sixteen have given a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat.com, Skyworks Solutions currently has a consensus rating of “Hold” and a consensus target price of $74.22.
Get Our Latest Analysis on Skyworks Solutions
Key Stories Impacting Skyworks Solutions Here are the key news stories impacting Skyworks Solutions this week:
Positive Sentiment: Skyworks reported fiscal third-quarter revenue of approximately $935 million and non-GAAP diluted EPS of $1.08, exceeding analyst expectations of about $926 million and $1.03, respectively. Growth in Broad Markets—particularly automotive and AI data-center applications—helped offset weakness in other businesses. Skyworks fiscal third-quarter results Positive Sentiment: Management issued fourth-quarter EPS guidance of $1.27, above the roughly $1.23 consensus estimate, with revenue guidance of $1.0 billion to $1.1 billion. The company also authorized a new $2 billion share-repurchase program, which could support per-share results over time. Skyworks Q3 release and capital allocation update Positive Sentiment: Skyworks and Qorvo announced expected leadership appointments for their planned combination. RBC described the transaction favorably, citing potential cost synergies and relatively stable core business trends. Regulatory approvals are progressing, although the deal remains pending. RBC view on the Qorvo transaction Neutral Sentiment: Analyst sentiment remains mixed. UBS raised its target to $70 while maintaining a Neutral rating, whereas JPMorgan, Morgan Stanley, Stifel, TD Cowen, Citigroup, RBC and Mizuho lowered targets, generally retaining Neutral, Hold or equivalent ratings. Analyst revisions following earnings Negative Sentiment: Revenue declined 3.1% year over year and EPS fell from $1.33 a year earlier, while margin pressure and weaker wireless-related demand overshadowed the quarterly beat. Investors may also be concerned about the reported dividend suspension and plans to raise approximately $2 billion in acquisition debt financing. Morgan Stanley analysis of Skyworks Hedge Funds Weigh In On Skyworks Solutions Institutional investors and hedge funds have recently made changes to their positions in the business. Pzena Investment Management LLC boosted its holdings in Skyworks Solutions by 27.6% in the first quarter. Pzena Investment Management LLC now owns 16,108,138 shares of the semiconductor manufacturer’s stock worth $862,591,000 after acquiring an additional 3,481,658 shares in the last quarter. Norges Bank purchased a new stake in shares of Skyworks Solutions in the fourth quarter worth $121,304,000. FIL Ltd grew its stake in shares of Skyworks Solutions by 50.5% in the fourth quarter. FIL Ltd now owns 5,190,211 shares of the semiconductor manufacturer’s stock worth $329,111,000 after acquiring an additional 1,742,338 shares during the last quarter. Capital Research Global Investors bought a new position in shares of Skyworks Solutions during the fourth quarter valued at $102,279,000. Finally, First Trust Advisors LP increased its holdings in shares of Skyworks Solutions by 51.7% during the first quarter. First Trust Advisors LP now owns 2,218,826 shares of the semiconductor manufacturer’s stock valued at $118,818,000 after acquiring an additional 756,280 shares in the last quarter. Institutional investors own 85.43% of the company’s stock.
Skyworks Solutions Trading Down 5.4% The firm has a 50-day moving average price of $68.95 and a 200-day moving average price of $62.84. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.70 and a current ratio of 2.38. The stock has a market cap of $9.20 billion, a PE ratio of 31.70 and a beta of 1.50.
Skyworks Solutions (NASDAQ:SWKS – Get Free Report) last announced its quarterly earnings data on Tuesday, July 28th. The semiconductor manufacturer reported $1.08 EPS for the quarter, beating the consensus estimate of $1.03 by $0.05. The company had revenue of $934.80 million for the quarter, compared to the consensus estimate of $925.97 million. Skyworks Solutions had a net margin of 7.23% and a return on equity of 10.73%. Skyworks Solutions’s revenue for the quarter was down 3.1% on a year-over-year basis. During the same period in the prior year, the firm posted $1.33 EPS. Skyworks Solutions has set its Q4 2026 guidance at 1.270-1.270 EPS. As a group, equities analysts anticipate that Skyworks Solutions, Inc. will post 3.62 EPS for the current fiscal year.
Skyworks Solutions Dividend Announcement The company also recently declared a quarterly dividend, which was paid on Tuesday, June 16th. Stockholders of record on Tuesday, May 26th were issued a dividend of $0.71 per share. The ex-dividend date was Tuesday, May 26th. This represents a $2.84 dividend on an annualized basis and a dividend yield of 4.6%. Skyworks Solutions’s dividend payout ratio is presently 117.84%.
About Skyworks Solutions (Get Free Report)
Skyworks Solutions, Inc is a leading semiconductor company that designs and manufactures analog and mixed-signal semiconductors for use in radio frequency (RF) and mobile communications markets. The company’s portfolio includes power amplifiers, front-end modules, switches, filters, low-noise amplifiers, and other components that enable wireless connectivity in smartphones, tablets, wearables, automotive telematics, and broadband infrastructure. With a focus on energy efficiency and integration, Skyworks serves a broad range of customers in the mobile, Internet of Things (IoT), automotive, connected home, and industrial end markets.
Headquartered in Irvine, California, Skyworks operates a network of design, development, and manufacturing facilities across North America, Europe, and the Asia-Pacific region.
Featured Articles Five stocks we like better than Skyworks Solutions Why SK hynix Could Be the Best AI Chip Stock to Buy Now Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead? Why Bloom Energy May Be the Most Important AI Infrastructure Stock Receive News & Ratings for Skyworks Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Skyworks Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINESoFi Technologies (NASDAQ:SOFI) Shares Gap Down After Insider Selling
NEXT HEADLINE »The Hanover Insurance Group (NYSE:THG) Hits New 52-Week High on Strong Earnings
Toyota Motor poprvé za dva roky vykázala pokles globální výroby i prodeje za první pololetí kvůli slabší poptávce v Číně a změně modelu RAV4. Globální prodeje klesly o 2,9 % na něco přes 5 milionů vozů. Globální výroba se snížila o 1,2 % na méně než 4,9 milionu vozů.
Toyota bZ7 electric sedan is displayed at the Beijing International Automotive Exhibition (Auto China), in Beijing, China, April 24, 2026. REUTERS/Tingshu Wang Purchase Licensing Rights, opens new tab
CompaniesTOKYO, July 30 (Reuters) - Toyota Motor (7203.T), opens new tab said on Thursday its global first-half production and sales fell for the first time in two years, as weaker demand in China and a model changeover for its popular RAV4 sport utility vehicle weighed on results.
Stay up to date with the latest news, trends and innovations that are driving the global automotive industry with the Reuters Auto File newsletter. Sign up here.
Global sales for January-June dropped 2.9% year-on-year to just over 5 million vehicles, as a 17.1% decline in China offset stronger demand in North America and Japan.
Global vehicle production shrank 1.2% year-on-year to under 4.9 million vehicles over the first six months of the year.
For June, global sales edged 0.1% higher to 868,454 vehicles and production was up 2.9% at 879,321 cars.
Toyota's figures include sales and production at its luxury brand Lexus.
Reporting by Daniel Leussink; Editing by Sherry Jacob-Phillips
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Margaret Kehan - Senior Director of Capital Markets & Investor Relations
Ernest Garcia - Co-Founder, President, CEO & Chairman
Mark Jenkins - Chief Financial Officer
Conference Call Participants
Daniela Haigian - Morgan Stanley, Research Division
John Colantuoni - Jefferies LLC, Research Division
Rajat Gupta - JPMorgan Chase & Co, Research Division
Ronald Josey - Citigroup Inc., Research Division
Brian Nagel - Oppenheimer & Co. Inc., Research Division
Sharon Zackfia - William Blair & Company L.L.C., Research Division
Andrew Boone - Citizens JMP Securities, LLC, Research Division
Jeffrey Lick - Stephens Inc., Research Division
John Babcock - Barclays Bank PLC, Research Division
Marvin Fong - BTIG, LLC, Research Division
Joseph Spak - UBS Investment Bank, Research Division
Michael McGovern - BofA Securities, Research Division
Christopher Pierce - Needham & Company, LLC, Research Division
Presentation
Operator
Hello, and welcome to the Carvana Second Quarter 2026 Earnings Call. [Operator Instructions] I will now turn the conference over to Meg Kehan, Investor Relations. Please go ahead.
Margaret Kehan
Senior Director of Capital Markets & Investor Relations
Thank you. Good afternoon, ladies and gentlemen, and thank you for joining us on Carvana's Second Quarter 2026 Earnings Conference Call. Please note that this call is being webcast and can be accessed along with our Q2 shareholder letter and supplemental financial tables, on the Investor Relations section of the company's corporate website at investors.carvana.com.
Joining me on the call today are Ernie Garcia, Chief Executive Officer; and Mark Jenkins, Chief Financial Officer. Before we get started, I would like to remind you that this discussion contains forward-looking statements within the meaning of the federal securities laws, including, but not limited to, Carvana's market opportunities and future financial results that involve risks and uncertainties that may cause actual results to differ materially from those discussed here.
Mirion Technologies ve 2. čtvrtletí zvýšila tržby o 19,7 % na 266,8 milionu USD a potvrdila celoroční výhled na očekávání silnější druhé poloviny roku. Růst táhly hlavně akvizice, organicky tržby stouply jen o 1 %.
Mirion Technologies NYSE: MIR reported second-quarter revenue growth of nearly 20%, driven largely by acquisitions, while organic growth remained modest and the company maintained its full-year outlook on expectations for a stronger second half.
Second-quarter revenue rose 19.7% year over year to $266.8 million. Acquisitions, primarily Paragon, accounted for about 18 percentage points of that growth, while organic revenue increased 1%, in line with management’s April expectations. Adjusted EBITDA increased 27.5% to $65 million, and the adjusted EBITDA margin expanded 150 basis points, supported by pricing and favorable product mix.
Chairman and CEO Tom Logan said rising orders and backlog, along with margin expansion in both operating segments, position the company for an acceleration in the second half of 2026. “We’re maintaining our 2026 full-year guidance, which implies a meaningful step-up in financial performance for the remainder of the year,” Logan said.
Get Mirion Technologies alerts:
Orders and backlog expand on nuclear demand Second-quarter orders increased 40% to $291 million including a $62 million contribution from Paragon and Certrec. Before acquisitions, core orders rose 10%. The company said nuclear power orders, excluding M&A, grew about 50%, with growth split between demand from the operating nuclear fleet and small modular reactor, or SMR, projects.
Mirion booked $49 million in SMR orders during the quarter, up $42 million from a year earlier. The company’s backlog exceeded $1.1 billion at quarter-end, nearly 40% higher than a year ago. Legacy backlog, excluding additions from Paragon and Certrec, was up 17%, while the legacy installed-base portion of backlog rose nearly 40% year over year.
Logan said the company sees several sources of demand from the existing nuclear fleet, including catch-up spending on deferred maintenance, plant life extensions and upgrades, and digital transformation initiatives. He noted that roughly 80% of Mirion’s nuclear-power revenue is tied to the installed base, producing recurring and repeat business.
Management also cited policy, financing and project developments supporting the nuclear market, including U.S. regulatory proposals intended to streamline licensing, a Department of Energy loan program for reactor construction, and activity in advanced reactor designs. Logan said Mirion, Paragon and Certrec participated in each of four advanced reactor designs that reached criticality under the DOE reactor pilot program.
Large-order momentum tempered by China cancellation Mirion said it won several large opportunities during the second quarter, including a previously disclosed Paragon SMR order, a second portion of another SMR order, and a portion of a radioactive-waste-handling order in its defense and diversified end market. During the first two weeks of July, the company received more than $50 million of large orders, including a European installed-base order and a U.S. Department of Energy order.
Those July awards were partly offset by the cancellation of a Chinese new-build order originally booked in 2019. The associated sites had made little progress amid geopolitical tensions, according to management. The cancellation had no impact on 2026 guidance and only an immaterial effect on Mirion’s long-range guidance, CFO and Medical Group President Brian Schopfer said.
Logan said Mirion does not view the cancellation as signaling broader backlog risk. He said the company remains active in China’s installed base, serving 50 of the country’s 60 operating reactors, and has continued to generate a predictable spare-parts business there. However, he acknowledged that the company has no content in China’s indigenous Hualong reactor program.
Mirion had approximately $160 million of large opportunity awards year to date and about $280 million of opportunities remaining. Management characterized its screening methodology as opportunities above $10 million where it sees a greater-than-50% probability of winning, while emphasizing that timing remains the primary risk.
Segment results and medical outlook Nuclear and Safety revenue increased 31% to $186 million, including 2.3% organic growth. Paragon revenue increased 15% in the quarter and 27% year to date. Nuclear and Safety adjusted EBITDA rose 35% to $51 million, while the segment margin expanded about 70 basis points. Favorable European product mix, cost control and a modest U.S. tariff refund helped offset dilution from the Paragon acquisition.
Although nuclear power orders were strong, organic revenue in that end market was flat, as growth in installed-base and SMR activity was offset by lower new-build revenue. Schopfer said new-build revenue can be uneven based on project timing, but Mirion continues to expect double-digit organic revenue growth in nuclear power for the full year.
Medical segment revenue declined 1% to $81 million, with organic revenue also down 1%. Revenue in radiation therapy quality assurance, or RTQA, continued to grow, but nuclear medicine revenue declined because of delayed hardware demand, and dosimetry faced a difficult comparison with a large prior-year hardware order.
Mirion raised its full-year RTQA organic-growth outlook to double digits from a prior expectation of mid-single-digit-plus growth. The company reduced its nuclear medicine outlook to mid-single-digit growth from a prior double-digit forecast, citing delayed hardware demand that it views as a delay rather than a demand decline. Dosimetry organic revenue is now expected to decline for the year, compared with a prior forecast for flat performance, due to lower hardware revenue and difficult comparisons. Despite the revised end-market assumptions, management said these changes largely offset one another and reiterated full-year Medical segment guidance.
Cash flow, repurchases and second-half expectations Mirion generated $49 million in adjusted free cash flow during the quarter and $60 million in the first half, which Schopfer called the company’s best first-half adjusted free-cash-flow performance since going public. The company attributed the result to higher adjusted EBITDA, working-capital performance, lower cash taxes and refinancing-related benefits.
The company repurchased about 1.4 million shares for approximately $25 million in the second quarter. Year-to-date repurchases totaled roughly $40 million, leaving $40 million authorized under the current program.
Management said approximately 81% of expected full-year revenue is covered by first-half results and backlog expected to convert during the second half, comparable with prior years. For the third quarter, Mirion expects high-single-digit consolidated organic revenue growth, including mid-single-digit growth in Nuclear and Safety and high-single-digit growth in Medical. Consolidated adjusted EBITDA margin is expected to expand year over year, although Nuclear and Safety margins are expected to contract because of Paragon dilution, incentive-compensation comparisons and a greater mix of lower-margin new-build revenue.
About Mirion Technologies (NYSE:MIR)Mirion Technologies Inc NYSE: MIR is a leading global provider of radiation detection, measurement and monitoring solutions. The company's portfolio includes instrumentation, software and service offerings designed to detect, quantify and manage radiation in nuclear power, oil and gas, defense and homeland security, medical imaging and diagnostic applications. Mirion's product suite spans personal and environmental dosimetry, area monitors, digital imaging detectors and turnkey solutions for decommissioning and environmental remediation projects.
Mirion traces its origins to the combination of several established radiation measurement businesses, including the former Canberra nuclear instrumentation division, and has been supported by private equity investors before completing its initial public offering on the New York Stock Exchange in 2023.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in Mirion Technologies Right Now?Before you consider Mirion Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mirion Technologies wasn't on the list.
While Mirion Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Humana uvedla, že výhled na rok 2026 je v souladu s očekáváním a míří k expanzi marže Medicare Advantage v roce 2027. Cílí na udržitelnou marži před zdaněním alespoň 3 % v roce 2028.
UnitedHealth Just Gave Wall Street a Clearer Turnaround SignalHumana NYSE: HUM said its 2026 performance is tracking in line with expectations, with management emphasizing planned Medicare Advantage margin expansion in 2027, progress in its Stars program and continued operating-cost reductions as key components of its path toward a sustainable pretax margin of at least 3% in 2028.
President and Chief Executive Officer Jim Rechtin said the company’s 2026 membership growth trajectory remains on track and that both new and returning members are performing as expected. He said Humana’s priority in preparing its 2027 Medicare Advantage, or MA, bids was to make the margin progress needed to remain on course for its 2028 target.
Get Humana alerts:
3 Stocks Doing the Heavy Lifting in Healthcare’s Rebound“We expect our targeted margin expansion in 2027 to be driven by our ongoing focus on clinical excellence and operating efficiency work, combined with adjustments to our plan mix and benefits,” Rechtin said.
2027 Medicare Advantage Plan Changes Chief Financial Officer Celeste Mellet said Humana expects to make “significant progress” in 2027 compared with 2026, although final results will depend on the size and composition of its membership. The company did not provide a specific margin target for 2027.
3 Healthcare Stocks Set to Benefit From the One Big Beautiful BillHumana expects targeted plan exits for 2027 to affect approximately 600,000 members. Mellet said the company intends to recapture a significant portion of those members, similar to its experience in 2025, when it recaptured just over 40% of affected membership.
The company said it will use plan exits to preserve higher-performing plans, particularly those with greater penetration of value-based care. Mellet described the strategy as removing the lower end of profitability and returns rather than making more uniform benefit reductions across the portfolio. She said most planned exits involve plans with ratings of 3.5 Stars or below for bonus year 2027, though she said the strategy was not principally a Stars-related decision.
Humana said its bids continue to assume cost trends consistent with its 2026 outlook. Mellet reiterated that the company expects all-in medical and pharmacy cost trend of 7% to 8% this year, including lower medical-cost trend and double-digit drug-cost trend. For 2027, she said drug trend is expected to increase modestly due to the health technology pipeline and newly released drugs.
Management also said it incorporates contingency into its bids because they are submitted well ahead of the coverage year.
Cost Trends and Operating Efficiency Mellet said medical costs have been within Humana’s expected range, with slight favorability concentrated in inpatient care. Based on roughly four months of completed claims data, she said the favorable inpatient trend was more concentrated among members served by value-based providers.
The company said it has seen both lower hospital admissions per thousand members and lower unit costs for admissions. Rechtin said Humana is pursuing site-of-service initiatives intended to steer members toward lower-cost and higher-quality settings through local contracting, provider incentives, benefit design and member education.
Humana’s consolidated operating-cost ratio declined 120 basis points year over year in the second quarter, according to Mellet. The company continues to expect an approximately 150-basis-point reduction for the full year. Management said operating-model efforts have generated hundreds of millions of dollars in value during the first half of 2026.
Among the actions cited by Rechtin were centralizing utilization-management operations from 11 markets into one team, expanding outsourcing in finance and human resources, optimizing information-technology vendor relationships and integrating CarePlus operations into Humana’s core platforms.
Mellet said earlier cost efforts were more tactical, while current work is increasingly transformational, including simplification of operations, organizational structures, data management and vendor relationships. She said Humana is not yet reflecting major benefits from technology initiatives but sees a longer-term opportunity.
Stars Progress and December Update Rechtin said Humana’s outlook for bonus year 2028 Stars results remains unchanged and that the company remains confident in its ability to return to top-quartile results. Humana defines that objective as Stars revenue per member per month that is 10% above the median of its peer group, rather than relying solely on the percentage of members enrolled in plans rated 4 Stars or higher.
The company said its rate of improvement in 11 of 12 selected HEDIS and patient-safety measures outpaced the historical compound annual growth rate over the prior four years. Rechtin said the measures were selected because Humana had consistent longitudinal data for comparison and that management believes they are representative of broader performance.
Humana said it does not know the industry thresholds that will ultimately determine Stars outcomes and therefore cannot guarantee a result when the final data are released. The company expects to enter its annual Stars blackout period once it receives plan preview information from the Centers for Medicare & Medicaid Services beginning in August, with final data expected in October.
For bonus year 2029, Humana said it remained 5% ahead of last year’s quality-improvement rate on a per-member basis in key HEDIS measures at the end of the second quarter. New members’ engagement levels were in line with, and on some measures above, those of renewing members, management said.
Humana plans to host a virtual investor update on Dec. 10. Rechtin said the company expects by then to have full visibility into bonus year 2028 Stars results and preliminary insights into 2027 membership trends. He characterized the event as a “mark to market” on existing commitments rather than a change in strategy or financial goals.
Capital Actions, Medicaid and Leadership Humana said it has agreed to divest its minority interest in Gentiva in a transaction valued at approximately $900 million and expected to close in the fourth quarter. Rechtin said proceeds will largely fund the company’s recent acquisition of MaxHealth.
The company also established $1.5 billion in contingent capital facilities using pre-capitalized trust securities, or PCAPS. Mellet said the facilities provide long-duration contingent liquidity without increasing balance-sheet leverage unless drawn, and Humana does not anticipate using them in the near or medium term.
In Medicaid, Humana said it was awarded a statewide Illinois Medicaid managed-care contract scheduled to begin in January 2027. Rechtin said Humana was the only new entrant awarded a contract alongside five incumbents.
Separately, the company announced that Paul Smith, Anthropic’s chief commercial officer, and Fred Crawford, the former president and chief operating officer of Aflac, will join Humana’s board of directors.
About Humana (NYSE:HUM)Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in Humana Right Now?Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Hayward NYSE: HAYW reported higher second-quarter sales and earnings, citing price realization, stable overall volume and continued demand in its North American installed-base aftermarket business, while maintaining its full-year 2026 outlook.
Net sales increased 6% to $318 million in the second quarter, following 5% growth in the prior-year period. Sales rose 9% in North America, including 7% from price realization and 2% from volume growth, while Europe and Rest of World sales declined 8% amid macroeconomic conditions and geopolitical disruption tied to conflicts in Ukraine and the Middle East.
President and Chief Executive Officer Kevin Holleran said the company’s first-half performance reflected the resilience of its aftermarket-focused business model and execution across its strategic initiatives. For the first half, net sales rose 9%, adjusted EBITDA increased 9%, and adjusted diluted earnings per share increased 18%.
Get Hayward alerts:
Second-Quarter Margins and Earnings Gross profit increased 8% to $155 million, while gross margin declined 50 basis points to 48.7%. Senior Vice President and Chief Financial Officer Eifion Jones said the margin pressure was anticipated, reflecting higher specialty-metal, freight and resin costs as well as the timing of surcharges and other mitigation efforts.
Despite the year-over-year decline, Holleran said the quarter produced Hayward’s second-highest quarterly gross margin since becoming a public company. The only higher result was recorded in the second quarter of 2025.
Adjusted EBITDA rose 5% to $93 million, while adjusted EBITDA margin declined 40 basis points year over year to 29.1%. Adjusted diluted EPS increased 8% to $0.26. Jones said Hayward continued to invest in sales and marketing, advanced engineering and customer service during the period.
In North America, net sales reached $278 million. U.S. sales increased 9%, while Canada sales rose 2%, with the Canadian result affected by a weather-related slow start to the season. North American gross margin declined 90 basis points to 50.4% because of inflationary pressures and the timing of mitigation actions.
Europe and Rest of World sales totaled $41 million. Europe sales declined 4%, while Rest of World sales fell 16%, primarily due to disruption from the conflict in the Middle East. However, segment gross margin rose 50 basis points to 37.9%, and adjusted segment income margin was unchanged at 18.1%.
Demand, Inventory and Market Position Holleran said demand remained solid in discretionary product categories including salt chlorine generators, automation and lighting. Commercial pool and industrial flow-control businesses also posted double-digit net sales growth in the first half, he said.
Management said channel inventory levels were consistent with seasonal patterns. Holleran described inventory exiting the second quarter as “very normal” and balanced among the company’s largest channel partners. Jones said the North American channel and primary European markets typically held slightly more than four months of inventory at this point in the year, which was approximately where Hayward stood at the end of June.
The company expects inventories to decline in absolute terms during the third quarter as sales outpace sales into the channel, before channel partners build inventory during the fourth quarter for the following season’s early-buy period. Jones said end-of-year days on hand typically rise as that inventory is pulled into the channel.
Addressing analyst questions about industry competition, Holleran said Hayward believes it has been gaining share over several years. He attributed that view to product innovation, sales and service investments, dealer support, domestic manufacturing, shorter lead times and products designed for replacement and upgrade opportunities.
Hayward said it is expanding its connected-product ecosystem through its OmniX platform and expects to open its sixth Hayward Hub training center in Atlanta during the fourth quarter. The company also said its use of artificial intelligence in customer service has enabled 98% of North American calls to be answered within one second, with 80% resolved without escalation to a live technical-service representative.
Refinancing, Cash Flow and Capital Returns During the quarter, Hayward amended its Term Loan B, extending its maturity to 2033 from 2028 and lowering its spread by 61 basis points. The $960 million loan is expected to reduce annual run-rate interest expense by approximately $6 million, Jones said.
The company also replaced its $425 million asset-based lending revolver, previously due in 2028, with an undrawn $425 million cash-flow revolver maturing in 2031. The new facility provides full availability without a borrowing-base limitation, according to management.
Net leverage fell to 1.5 times at quarter-end from 2.1 times a year earlier, the lowest level since Hayward’s 2021 initial public offering. The company ended the quarter with $483 million in cash equivalents and short-term investments and said total liquidity, including credit-facility availability, exceeded $900 million.
Cash flow from operations was $172 million in the first half, compared with $188 million a year earlier. Free cash flow was $154 million, and the company continues to forecast approximately $200 million of free cash flow for the full year.
Hayward repurchased approximately 4.4 million shares for about $64 million during the first half. Management said its capital-allocation priorities remain organic investment in manufacturing and supply-chain capabilities, strategic acquisitions and opportunistic share repurchases.
Outlook Maintained Hayward reaffirmed its 2026 outlook, forecasting net sales growth of approximately 5% and adjusted diluted EPS growth of approximately 9% to 13%, or $0.84 to $0.87 per share. The outlook assumes net interest expense of about $45 million, a normalized effective tax rate of roughly 24% and capital expenditures of about $40 million.
Jones said Hayward expects full-year gross margins to remain approximately in line with the prior year. Management said it intends to use pricing actions to offset necessary inflation dollar for dollar while relying on productivity, cost-reduction initiatives, nearshoring, dual sourcing and value engineering to preserve structural margins.
About Hayward (NYSE:HAYW)Hayward Holdings, Inc is a leading manufacturer and marketer of residential and commercial swimming pool equipment and related outdoor living products. The company designs, engineers and produces a comprehensive range of products that address water circulation, filtration, heating, sanitation, automation, lighting and cleaning needs for pools and spas. Hayward's offerings include pumps, filters, heaters, salt and chemical sanitization systems, automation controls, lights, robotic cleaners and various accessories that serve both new pool construction and aftermarket renovation markets.
Hayward's product portfolio is organized into several core categories.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in Hayward Right Now?Before you consider Hayward, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hayward wasn't on the list.
While Hayward currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
New eTurbo™ program expands BorgWarner's electrified boosting business with a major OEM New generation features remote power electronics for greater integration flexibility Delivers 20 kW of continuous electrical power and up to 30 kW peak, providing instant power and enabling energy recuperation , /PRNewswire/ -- BorgWarner has been awarded a new eTurbo™ program with a major European OEM for an advanced hybrid passenger car application, further strengthening BorgWarner's leading position in electrified boosting technologies. Production is scheduled to begin in 2029.
BorgWarner Secures New eTurbo™ Program with Major European OEM "This new award underlines the strength of our eTurbo™ technology and the trust our customers place in BorgWarner's electrified boosting solutions," said Dr. Volker Weng, President and General Manager, BorgWarner Turbos and Thermal Technologies. "By continuing to evolve our proven 400-volt eTurbo™ platform, we are helping our customers meet some of the industry's most demanding requirements for performance, efficiency and emissions compliance."
The BorgWarner eTurbo™ is an electrically assisted turbocharger that integrates a high-speed electric motor directly on the turbo shaft to actively drive the compressor. The system eliminates turbo lag, enables significantly faster boost pressure build-up, and delivers 20 kW of continuous electrical power and up to 30 kW peak for both performance enhancement and energy recuperation. Excess exhaust energy is converted into electrical energy and fed back into the vehicle's high-voltage system rather than being lost through a conventional wastegate.
The new program is based on a continuous evolution of BorgWarner's proven eTurbo™ platform currently in series production. A key new feature is the introduction of remote power electronics, which allow flexible positioning within the vehicle and engine compartment, supporting integration into the most challenging packaging environments. Designed for operating speeds of up to 145,000 rpm and exhaust gas temperatures above 1,000°C, the system combines advanced cooling strategies with high-performance silicon carbide based power electronics to ensure efficiency, durability and reliability under the most demanding operating conditions.
Beyond performance, the eTurbo™ plays an important role in helping automakers meet upcoming emissions regulations such as Euro 7 (EU7), Super Ultra-Low Emission Vehicle (SULEV), and China National 6b Emissions Standards (C6b) by eliminating fuel enrichment at high load, reducing exhaust backpressure and converting otherwise lost exhaust energy into usable electrical power. With proven series production and extensive field experience, BorgWarner remains the only supplier offering a 400-volt eTurbo™ in series.
About BorgWarner
For more than 130 years, BorgWarner has been a transformative global product leader bringing successful mobility innovation to market. With a focus on sustainability, we're helping to build a cleaner, healthier, safer future for all.
Forward-Looking Statements: This press release contains forward-looking statements as contemplated by the 1995 Private Securities Litigation Reform Act that are based on management's current outlook, expectations, estimates and projections. Words such as "anticipates," "believes," "continues," "could," "designed," "effect," "estimates," "evaluates," "expects," "forecasts," "goal," "guidance," "initiative," "intends," "may," "outlook," "plans," "potential," "predicts," "project," "pursue," "seek," "should," "target," "when," "will," "would," and variations of such words and similar expressions are intended to identify such forward-looking statements. Further, all statements, other than statements of historical fact contained or incorporated by reference in this press release that we expect or anticipate will or may occur in the future regarding our business strategy, competitive strengths, goals, expansion and growth of our business and operations, plans, references to future success and other such matters, are forward-looking statements. All forward-looking statements are based on assumptions and analyses made by us in light of our experience and our perception of historical trends, current conditions and expected future developments, as well as other factors we believe are appropriate under the circumstances. Forward-looking statements are not guarantees of performance, and the Company's actual results may differ materially from those expressed, projected or implied in or by the forward-looking statements.
You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Forward-looking statements are subject to risks and uncertainties, many of which are difficult to predict and generally beyond our control, that could cause actual results to differ materially from those expressed, projected or implied in or by the forward-looking statements. These risks and uncertainties, among others, include: the possibility that our turbocharging technology will not achieve their intended benefits; the supply disruptions impacting us or our customers, commodity availability and pricing; conditions in the automotive industry; competitive challenges from existing and new competitors, including original equipment manufacturer ("OEM") customers; the challenges associated with rapidly changing technologies, including artificial intelligence, and our ability to innovate in response; potential future changes in laws and regulations, including, by way of example, taxes and tariffs, in the countries in which we operate; potential disruptions in the global economy caused by wars or other geopolitical conflicts; our dependence on automotive and truck production, which is highly cyclical and subject to disruptions; our reliance on major OEM customers; impacts of any future strikes involving any of our OEM customers and any actions such OEM customers take in response; fluctuations in interest rates and foreign currency exchange rates; our dependence on information systems; the uncertainty of the global economic environment; the uncertainty surrounding global trade policies, including tariffs and export restrictions, and their impacts on the Company, its customers and its suppliers; the outcome of existing or any future legal proceedings, including litigation with respect to various claims, or governmental investigations, including related litigations; impacts from any potential future acquisition or disposition transactions; and the other risks discussed in reports that we file with the Securities and Exchange Commission, including in Item 1A, "Risk Factors" in our most recently-filed Annual Report on Form 10-K and/or Quarterly Report on Form 10-Q. We do not undertake any obligation to update or announce publicly any updates to or revisions to any of the forward-looking statements in this release to reflect any change in our expectations or any change in events, conditions, circumstances, or assumptions underlying the statements.
Kaplan Fox vyšetřuje možné porušení pravidel u Fulcrum Therapeutics po ukončení programu pociredir pro léčbu srpkovité anémie. Akcie po oznámení 1. června 2026 klesly o 51,09 %.
New York, New York--(Newsfile Corp. - July 29, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Fulcrum Therapeutics, Inc. ("Fulcrum Therapeutics" or the "Company") (NASDAQ: FULC).
CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION
If you are a Fulcrum Therapeutics investor and have suffered losses, or if you have information that could assist in the Fulcrum Therapeutics investigation, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing [email protected] or by calling (212) 329-8571.
Fulcrum Therapeutics is a "clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with rare hematological disorders[.]"
On June 1, 2026, after market close, Fulcrum Therapeutics announced in a press release "the discontinuation of its pociredir program for the treatment of SCD [(sickle cell disease).]" The Company stated that the "meeting minutes from recent end-of-phase interactions with the [U.S. Food and Drug Administration ("FDA")]" "reflected heightened FDA concerns regarding pociredir's benefit-risk profile in SCD, stemming from an unexpectedly high rate of secondary hematologic malignancies observed with Tazverik® (tazemetostat), another PRC2 inhibitor, which was withdrawn from the global market in March 2026." After submitting further information, the FDA "concluded that any pharmacological intervention targeting the PRC2 complex carries equivalent malignancy risk regardless of the specific subunit engaged." As a result, the Company has "no viable regulatory path forward for further clinical development of pociredir."
Following this news, the price of Fulcrum Therapeutics stock declined from a closing price on June 1, 2026 of $6.42 per share to close at $3.14 per share on June 2, 2026, a decline of $3.28 per share, or by 51.09%.
WHY CONTACT KAPLAN FOX?
Kaplan Fox & Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nationwide, recovering more than $10 billion for clients and the classes it has represented.
Kaplan Fox is widely regarded as one of the nation's premier plaintiffs' securities litigation firms and has received recognition from Chambers and Partners, Benchmark Litigation, Super Lawyers, and Lawdragon. Serving as lead or co-lead counsel in many landmark cases, the firm has secured some of the largest recoveries in the history of securities litigation, including a $2.425 billion recovery on behalf of Bank of America shareholders in In re Bank of America—the largest recovery ever obtained for claims under Section 14(a) of the Securities Exchange Act—$800 million recovered for the Arkansas Teacher Retirement System and other pension funds in ATRS v. Allianz Global Investors, and a $475 million settlement in In re Merrill Lynch.
For decades, Kaplan Fox has represented public pension funds, institutional investors, businesses, and individuals in high-stakes litigation. Through its successful advocacy and precedent-setting victories, the firm has helped shape important areas of securities and corporate law while advancing accountability and protecting investor interests.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
If you have any questions about this investigation, please contact:
Contacting or submitting information to Kaplan Fox & Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client.
Fresh Del Monte Produce zvýšila výhled pro Del Monte Foods na rok 2026 na tržby 625 milionů USD a upravenou EBITDA 35 milionů USD po ziskovém prvním plném čtvrtletí po akvizici.
Small-Caps, Big Buybacks: 3 Stocks With Large Buyback CapacityFresh Del Monte Produce NYSE: FDP said its newly acquired Del Monte Foods business delivered profitable performance in its first full quarter under company ownership, prompting management to raise its 2026 sales and adjusted EBITDA outlook for the prepared-foods unit.
During the company’s second-quarter 2026 earnings call, Chairman and Chief Executive Officer Mohammad Abu-Ghazaleh said the company is now operating as Del Monte Corporation following its acquisition of Del Monte Foods in March. He characterized the combination as creating two complementary businesses: the company’s global fresh-produce operations and a shelf-stable prepared-foods platform with higher margins, longer shelf life and established brand loyalty.
Get FDP alerts:
Dole is a Tasty Low Hanging Treat for Value Hunters “By the end of the second quarter, I’m proud to announce that our Foods division delivered profitable performance,” Abu-Ghazaleh said, adding that the business has established an operational base for its planned growth strategy.
Del Monte Foods outlook raised Senior Vice President and Chief Financial Officer Monica Vicente said the company now expects Del Monte Foods to generate 2026 net sales of $625 million and adjusted EBITDA of $35 million. Those projections were raised from prior expectations for $600 million in sales and $23 million in adjusted EBITDA.
Vicente said the company has undertaken pricing actions, product-portfolio changes and trade-spending optimization initiatives that are expected to contribute about $9 million in annual margin expansion as they are phased in during 2026 and 2027.
Management cited improved service levels, product-line rationalization and logistics work among the early accomplishments at Del Monte Foods. Abu-Ghazaleh said the business had addressed issues including service levels and product shortages, reaching on-time delivery performance of 95% or more. The company is also pursuing further efficiencies in storage and warehousing over the next 12 months.
The company said it expects to introduce certain new products toward the end of 2026, with additional launches anticipated in 2027. Abu-Ghazaleh pointed to a planned packaged Pinkglow pineapple product as one example of potential collaboration between the fresh and prepared-foods businesses, saying it could reach the market within several months.
Quarterly results and full-year targets For the second quarter, Vicente reported net sales of $1.22 billion, up 3% from a year earlier. On an adjusted basis, net sales increased 9%. Gross profit was $121 million, representing a 9.9% gross margin.
Adjusted operating income was $49 million. Adjusted net income was $34 million. Adjusted diluted earnings per share were $0.72. Adjusted EBITDA was $72 million, or a 6% margin. For full-year 2026, the company expects adjusted net sales growth of 13% to 15% and adjusted EBITDA between $230 million and $240 million. Vicente said the company’s estimate for external cost pressures has declined to $45 million to $55 million, compared with its earlier forecast of $60 million to $70 million.
The improvement reflects lower pressure from bunker fuel, diesel and fertilizer costs, as well as changes in purchasing practices for raw materials, Vicente said. She noted, however, that the Costa Rican colón remains a headwind.
The company reaffirmed gross-margin targets of 11% to 12% for fresh and value-added products, 3% to 4% for bananas, 14% to 15% for prepared products, and 10% to 11% for other products and services.
Banana footprint changes and pineapple investment Management said it is adjusting its Costa Rican agricultural footprint, including closing certain banana farms that have become less viable because of higher costs and competitive pressure. Vicente said four farms being closed represented about 5% of the company’s Costa Rican banana production.
Abu-Ghazaleh said the company has rationalized banana volumes rather than participate in pricing conditions that he described as unsustainable. He said competition has been particularly severe over the past six to seven months, while higher costs at origin have also affected the category.
Some of the land will be repurposed toward higher-margin pineapple offerings, including Del Monte Gold and Honeyglow pineapples. Management said the immediate benefit from farm closures will be the elimination of operating losses, while pineapple production will take longer to develop. Vicente said pineapples have a growing cycle of roughly three to four years, though Abu-Ghazaleh said the company may be able to accelerate the conversion process and begin seeing pineapple production at least two years after closures.
Pineapple sales were strong during the quarter, according to Vicente, although volume was somewhat lower than the prior year because of the crop-growing cycle. She said pricing was higher, while costs were affected by fertilizer, diesel and currency pressures.
Management also said fresh-cut operations remained consistent year over year. The business faced sourcing and shipping difficulties involving Mexico, Brazil and Peru, but demand and sales pricing remained strong, according to executives.
Liquidity, capital spending and shareholder returns The company expanded its revolving credit facility to $900 million from $750 million earlier in July, with terms maintained through February 2029. Vicente said the additional capacity is intended to support liquidity through seasonal harvest cycles and working-capital normalization.
Operating cash flow totaled $94 million during the first half of 2026. The company expects full-year capital expenditures of $85 million to $95 million, directed toward Central American expansion projects, European fresh-cut growth, investments in Del Monte Foods and technology.
The board declared a quarterly cash dividend of $0.30 per share, or $1.20 on an annualized basis. The company also repurchased $16 million of common stock during the quarter.
About Fresh Del Monte Produce (NYSE:FDP)Fresh Del Monte Produce Inc is a leading producer, marketer and distributor of fresh and fresh-cut fruits and vegetables worldwide. The company offers a wide range of products including bananas, pineapples, melons, grapes and avocados, along with value-added items such as fruit salads, vegetable trays and snack packs under the Del Monte® brand.
Founded in 1989 as a spin-off from Del Monte, Fresh Del Monte has developed a global supply chain that spans production farms, ripening facilities and packaging centers across Latin America, North America, Europe, Asia and Africa.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in Fresh Del Monte Produce Right Now?Before you consider Fresh Del Monte Produce, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fresh Del Monte Produce wasn't on the list.
While Fresh Del Monte Produce currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Jensen Huang věří, že AI revoluce teprve začíná, a očekává, že Nvidia do roku 2027 dosáhne tržeb 1 bilion USD z čipů. CFO Colette Kress navíc odhaduje roční investice do AI infrastruktury na 3 až 4 biliony USD do konce dekády.
Nvidia (NVDA -3.55%) recently gave up its seat as the world's most valuable company. That title now belongs to Apple, whose shares are up 25% in 2026 (as of July 28). This significantly exceeds the artificial intelligence (AI) stock's muted 6% gain this year.
But it wasn't long ago that Nvidia's market capitalization was firmly above $5 trillion, something that could happen again very soon. Investors worried about the shares' latest fall will take solace in CEO Jensen Huang's bullish call from several weeks ago on the prospects of the AI market.
Image source: Nvidia.
One of the most credible AI executives is telling investors to be optimistic When he was in Seoul, South Korea, in early June, Huang essentially told investors to act aggressively when there's market weakness. At the time, chip stocks were selling off, a rout that's continuing now. Anytime shares in these companies take a hit, it's time to be a buyer, Huang believes.
He thinks the AI revolution is just getting started. During Nvidia's GTC conference in March, Huang said that the business will collect $1 trillion in sales from its chips through 2027, double the previous $500 billion forecast through 2026.
And chief financial officer Colette Kress believes that spending on AI infrastructure will total $3 trillion to $4 trillion by the end of the decade. This isn't a cumulative figure; the colossal sum is an annual outlook. These numbers reveal management's firm belief that demand isn't going anywhere.
Nvidia sits at the center of the AI boom Of course, Nvidia's CEO has every reason to downplay any of the market's concerns regarding the mind-boggling AI build-out. His goal is to drive ongoing optimism among investors. After all, his business is at the heart of the infrastructure boom, providing powerful graphics processing units that data centers need to run AI models. However, given Nvidia's monster success, with revenue and net income up 85% and 211%, respectively, year over year during Q1 2027 (ended April 26), Huang's perspective is definitely credible.
Nvidia might have more skin in the AI game than any other company. For example, it invested $30 billion in OpenAI in March and has taken equity stakes in many other companies. And it's reportedly looking to guarantee $250 billion in financing for OpenAI so the leading AI lab can lease a new data center in Ohio. Nvidia also repurchased $19 billion of its own stock last quarter.
Today's Change
(
-3.55
%) $
-7.00
Current Price
$
190.01
Watch the hyperscalers Alphabet, a hyperscaler that's rapidly expanding its computing capacity, just raised its 2026 forecast for capital expenditures (capex) to $200 billion (at the midpoint). This shows that the spending isn't letting up. In fact, it's rising.
Based on recent trends, there's a high likelihood that the other hyperscalers will also bump up their capex plans when they report financial results later this week.
The biggest unknown, though, is whether the investment community believes in the durability of this AI revolution. That's the multitrillion-dollar question the market is facing. Jensen Huang will certainly do his best to drive investor bullishness.
Fortinet, Inc. (FTNT) Q2 2026 Earnings Call July 29, 2026 4:30 PM EDT
Company Participants
Anthony Luscri - Vice President of Investor Relations
Ken Xie - Co-Founder, Chairman & CEO
Christiane Ohlgart - Chief Accounting Officer, CFO and Principal Financial & Accounting Officer
John Whittle - Chief Operating Officer
Conference Call Participants
Saket Kalia - Barclays Bank PLC, Research Division
Shaul Eyal - TD Cowen, Research Division
Gray Powell - BTIG, LLC, Research Division
Keith Bachman - BMO Capital Markets Equity Research
Meta Marshall - Morgan Stanley, Research Division
Fatima Boolani - Citigroup Inc., Research Division
Gabriela Borges - Goldman Sachs Group, Inc., Research Division
Junaid Siddiqui - Truist Securities, Inc., Research Division
Joseph Gallo - Jefferies LLC, Research Division
Presentation
Operator
Hello, and welcome to the Fortinet's Second Quarter 2026 Earnings Conference Call. [Operator Instructions] Please be advised that this call is being recorded. I would now like to hand the call over to Anthony Luscri, Vice President of Investor Relations. Please go ahead.
Anthony Luscri
Vice President of Investor Relations
Thank you. Good afternoon, and thank you for joining us on today's conference call to discuss Fortinet's Second Quarter 2026 financial results. Joining me on today's call are Ken Xie, Fortinet's Founder, Chairman and CEO; Christiane Ohlgart, our CFO; and John Whittle, our COO. Ken will begin our call today by providing a high-level perspective on our business, Christiane will then review our financial results for the second quarter of 2026 before providing guidance for the third quarter and updating the full year. We will then open the call for questions.
During the Q&A session, we ask that you please limit yourself to one question and one follow-up question to all. Before we begin, I'd like to remind everyone that on today's call, we will be making forward-looking statements, and these forward-looking statements are subject to risks and uncertainties, which could cause actual
Robbins LLP vyšetřuje Pentair plc kvůli možnému porušení zákonů o cenných papírech a fiduciárních povinností vůči akcionářům. Firma po slabších výsledcích snížila celoroční výhled tržeb i upraveného EPS.
SAN DIEGO, July 29, 2026 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating Pentair plc (NYSE: PNR) to determine whether certain Pentair plc officers and directors violated securities laws and breached fiduciary duties to shareholders. Pentair plc provides various water solutions in the United States, Western Europe, China, Latin America, the Middle East, Southeast Asia, Australia, and Canada.
On April 28, 2026, Pentair projected that second-quarter sales would increase approximately 1% and that full-year sales would grow approximately 2% to 4%. During the accompanying earnings call, management acknowledged that Pool distributors could reduce purchases during the second and third quarters but stated that the Company had evaluated a wider range of Pool revenue and income scenarios and incorporated those assumptions into its updated guidance. Management further stated that it had reflected the expected second- and third-quarter sell-in pressure in its guidance.
On July 14, 2026, after the market closed, Pentair disclosed preliminary second-quarter sales of approximately $930 million, representing a decline of approximately 17% compared with its previous forecast of approximately 1% growth. Pentair attributed the results primarily to the adverse impact of Pool channel inventory and estimated that Pool inventory destocking reduced second-quarter Pool sales by approximately $170 million and Pool segment income by approximately $105 million. The Company stated that the inventory realignment with major channel partners was “more pronounced” than previously estimated.
Pentair also substantially reduced its full-year outlook. The Company now expects annual sales to decline approximately 4% to 7%, compared with its previous forecast of 2% to 4% growth, and reduced its adjusted earnings-per-share guidance to approximately $4.60 to $4.80 from approximately $5.30 to $5.40. Pentair estimated that Pool channel destocking and inventory right-sizing would reduce full-year Pool sales by approximately $250 million and Pool segment income by approximately $155 million. The Company separately announced that Chief Financial Officer Nicholas Brazis had departed on July 10, 2026, and that former Pentair CFO Bob Fishman had been appointed interim CFO.
Following the disclosure, Pentair shares declined approximately 22% in premarket trading on July 15, 2026, after closing at $75.68 on July 14, 2026.
What Now: If you lost money in your investment of Pentair plc, contact Robbins LLP for information about your rights.
All representation is on a contingency fee basis. Shareholders pay no fees or expenses.
Contact us to learn more:
Aaron Dumas, Jr.
(800) 350-6003 [email protected]
Shareholder Information Form
About Robbins LLP: A recognized leader in shareholder rights litigation, Robbins LLP has helped restore more than $1 billion in value to shareholders, secured some of the largest recoveries in shareholder derivative litigation history, and achieved governance reforms at over 400 Fortune 1000 companies.
"Behind everything we do is the belief that companies should be governed responsibly, fiduciaries should be held accountable, and shareholders deserve transparency and fairness," said Brian J. Robbins, Founding Partner of Robbins LLP.
To be notified if a class action against Pentair plc settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.
Attorney Advertising. Past results do not guarantee a similar outcome.
Chipotle ve 2. čtvrtletí zvýšila tržby o 9,3 % na 3,3 miliardy USD a upravila celoroční výhled růstu srovnatelných tržeb na nízké jednociferné tempo. Zisk na akcii byl 0,33 USD, meziročně beze změny.
Investors Are Buying Into Sweetgreen Again—Should They?Chipotle Mexican Grill NYSE: CMG reported second-quarter revenue growth of 9.3% to $3.3 billion, supported by a 2.2% increase in comparable restaurant sales and a 1% increase in comparable transactions. The company said its “Recipe for Growth” strategy, including menu innovation, restaurant execution investments and rewards-program changes, contributed to the quarter’s results.
Adjusted diluted earnings per share were $0.33, unchanged from the prior year. Restaurant-level margin was 25.2%, down 220 basis points year over year, as higher food, labor, marketing and other operating costs offset pricing and certain commodity benefits.
Get Chipotle Mexican Grill alerts:
Sales Momentum and Updated Outlook Shake Shack Stock Gets Shaken After Earnings MissChief Financial Officer Adam Rymer said traffic improved through the second quarter and into the first half of July. However, trends softened in the second half of July amid broader consumer caution in the restaurant industry and concern surrounding Cyclospora.
Rymer said Chipotle observed roughly a 200-basis-point sales impact around the industry issue and now expects third-quarter comparable sales growth of approximately 1%, assuming that impact persists through the remainder of the quarter. Chief Executive Officer Scott Boatwright said the company is not involved in the Cyclospora matter and does not use the products implicated in the discussion, adding that its lettuce is sourced in California.
Chipotle Stock Just Hit Bottom—Is a Breakout Next?For the full year, the company raised its outlook and now expects comparable restaurant sales growth in the low single-digit range. Pricing contributed approximately 1.6% in the second quarter and is expected to rise to the mid-2% range in the third quarter. Chipotle expects full-year pricing to land near the high end of its previously communicated 1% to 2% range.
Digital sales totaled $1.3 billion, representing 38.3% of sales, compared with 35.5% a year earlier. Boatwright attributed digital momentum in part to changes in the rewards program, including more personalized offers, simplified enrollment and expanded redemption options.
Restaurant Execution and Technology Investments Management highlighted continued investments intended to improve speed, food quality and hospitality in restaurants. The company deployed its “Linebacker” staffing approach in more than 70% of restaurants during the quarter and said its focus on execution helped improve “Max 15” peak-period throughput for a second consecutive quarter.
Chipotle’s High-Efficiency Equipment Package, or HEAP, has now been installed in more than 1,000 restaurants. The company expects to reach approximately 2,000 locations by year-end and complete the portfolio rollout sometime in 2027. According to Boatwright, restaurants using HEAP are outperforming the broader system by two to three entrees during their peak 15-minute period, with the gains contributing to comparable-sales improvements.
The company said it is reinvesting labor efficiencies from the equipment package back into restaurants, enabling more staffing during preparation and peak periods. It also is rolling out its Chipotle Kitchen digital make-line interface across restaurants, which management said has shown early improvements in order accuracy, on-time fulfillment and guest satisfaction.
Chipotle plans to begin piloting a frictionless in-restaurant rewards experience in August that would enable guests to earn points automatically when paying, without separately scanning a rewards card. The company said only about 20% of in-restaurant transactions currently scan for rewards, compared with nearly 90% of its own digital transactions. New in-store enrollment tools have driven a nearly 20% increase in daily enrollments since their launch, management said.
Menu Innovation, Marketing and Consumer Trends Chipotle Honey Chicken returned during the quarter and outperformed its prior launch, Boatwright said, reaching a cumulative attachment rate above 25%. Cilantro Lime Sauce also continued to generate attachment rates above those of Red Chimichurri and Adobo Ranch, according to management.
The company expects to introduce two additional limited-time protein offerings in the second half of 2026, while also pursuing innovation in beverages, sides and desserts. Boatwright said limited-time offerings can bring new guests to the brand and increase the lifetime value of customers who try them, while encouraging existing customers to visit more often.
Chipotle also cited marketing campaigns and rewards promotions as contributors to engagement. Its Matchday BOGO promotion set a company single-day sales record and became its most successful BOGO promotion, Boatwright said. Management added that younger customers and lower- to middle-income guests, which had faced more pressure previously, showed the greatest improvement in the second quarter.
Boatwright said the company’s brand tracker showed progress in value perceptions across income groups and age cohorts. He emphasized that value is not solely tied to discounting, but also includes convenience, execution, menu innovation, food quality and portions.
Development, Margins and Capital Allocation Chipotle opened 101 restaurants during the quarter, including 80 Chipotlanes and one international partner-operated restaurant. The company continues to expect approximately 350 openings during 2026, with about 80% including a Chipotlane. Management said new-restaurant productivity has remained in the 80% range, while year-two cash-on-cash returns have continued at approximately 60%.
The company believes North America can support at least 7,000 restaurants. In Europe, each country delivered high-single-digit comparable-sales growth during the quarter, according to Boatwright. Chipotle also opened its first restaurant in Monterrey, Mexico, and plans additional Monterrey-area openings this year before expanding to Mexico City in 2027. First locations in Seoul are expected this year, followed by Singapore in early 2027.
Cost of sales rose about 80 basis points to 29.7% of sales in the second quarter, primarily due to beef and freight inflation and increased usage of chicken, steak and produce. Labor costs increased about 30 basis points to 25%, while other operating costs rose about 90 basis points to 14.9%, driven partly by higher marketing, insurance, maintenance and utility expenses.
Chipotle ended the quarter with $800 million in cash, restricted cash and investments and no debt. The company repurchased $631 million of stock during the quarter at an average price of $32.55 per share, bringing year-to-date repurchases to more than $1.3 billion. Its board authorized an additional $1.3 billion for repurchases, leaving $1.7 billion available at quarter-end.
About Chipotle Mexican Grill (NYSE:CMG)Chipotle Mexican Grill is a fast-casual restaurant company known for its Mexican-inspired menu of burritos, bowls, tacos and salads. Founded in 1993 by Steve Ells, the chain emphasizes fresh, customizable meals made from a limited menu of core ingredients and a focus on ingredient quality. Chipotle operates primarily company-owned restaurants and offers dine-in, takeout, catering and delivery through its own digital platforms and third-party partners.
The company is headquartered in Newport Beach, California, and traces its roots to Denver, Colorado.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in Chipotle Mexican Grill Right Now?Before you consider Chipotle Mexican Grill, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chipotle Mexican Grill wasn't on the list.
While Chipotle Mexican Grill currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
FMC (FMC - Free Report) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.69 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +23.81%. A quarter ago, it was expected that this chemical producer would post a loss of $0.39 per share when it actually produced a loss of $0.23, delivering a surprise of +41.03%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
FMC, which belongs to the Zacks Agriculture - Operations industry, posted revenues of $841.4 million for the quarter ended June 2026, missing the Zacks Consensus Estimate by 7.03%. This compares to year-ago revenues of $1.05 billion. The company has topped consensus revenue estimates just once over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
FMC shares have lost about 21.1% since the beginning of the year versus the S&P 500's gain of 8.5%.
What's Next for FMC?While FMC has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for FMC was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #5 (Strong Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.61 on $940.28 million in revenues for the coming quarter and $1.61 on $3.7 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Agriculture - Operations is currently in the top 40% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, Cibus (CBUS - Free Report) , is yet to report results for the quarter ended June 2026.
This developer and licensor of plant traits for seed companies is expected to post quarterly loss of $0.26 per share in its upcoming report, which represents a year-over-year change of +57.4%. The consensus EPS estimate for the quarter has been revised 18.6% higher over the last 30 days to the current level.
Cibus' revenues are expected to be $1.41 million, up 51.6% from the year-ago quarter.
Markel Group vykázala zisk na akcii 19,51 USD, což zaostalo za odhadem 29,94 USD a bylo méně než 25,46 USD před rokem. Tržby ve výši 4,02 miliardy USD ale překonaly odhad o 8,61 %.
Markel Group (MKL - Free Report) came out with quarterly earnings of $19.51 per share, missing the Zacks Consensus Estimate of $29.94 per share. This compares to earnings of $25.46 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -34.84%. A quarter ago, it was expected that this insurer would post earnings of $26.38 per share when it actually produced earnings of $21.61, delivering a surprise of -18.08%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.
Markel Group, which belongs to the Zacks Insurance - Multi line industry, posted revenues of $4.02 billion for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 8.61%. This compares to year-ago revenues of $4.02 billion. The company has topped consensus revenue estimates two times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Markel Group shares have lost about 5.1% since the beginning of the year versus the S&P 500's gain of 8.5%.
What's Next for Markel Group?While Markel Group has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Markel Group was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $28.60 on $4.3 billion in revenues for the coming quarter and $114.11 on $16.23 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Insurance - Multi line is currently in the bottom 32% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Another stock from the same industry, Equitable Holdings, Inc. (EQH - Free Report) , has yet to report results for the quarter ended June 2026. The results are expected to be released on August 4.
This company is expected to post quarterly earnings of $1.66 per share in its upcoming report, which represents a year-over-year change of +50.9%. The consensus EPS estimate for the quarter has been revised 2.2% higher over the last 30 days to the current level.
Equitable Holdings, Inc.'s revenues are expected to be $3.8 billion, down 0% from the year-ago quarter.
Ingevity (NGVT - Free Report) came out with quarterly earnings of $1.74 per share, beating the Zacks Consensus Estimate of $1.31 per share. This compares to earnings of $1.39 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +32.82%. A quarter ago, it was expected that this company would post earnings of $0.84 per share when it actually produced earnings of $1.15, delivering a surprise of +36.9%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.
Ingevity, which belongs to the Zacks Chemical - Specialty industry, posted revenues of $314.1 million for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 4.91%. This compares to year-ago revenues of $365.1 million. The company has topped consensus revenue estimates two times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Ingevity shares have added about 25.9% since the beginning of the year versus the S&P 500's gain of 8.5%.
What's Next for Ingevity?While Ingevity has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Ingevity was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.64 on $304.7 million in revenues for the coming quarter and $5.05 on $1.12 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Chemical - Specialty is currently in the top 38% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Another stock from the same industry, Linde (LIN - Free Report) , has yet to report results for the quarter ended June 2026. The results are expected to be released on July 31.
This gas supplier is expected to post quarterly earnings of $4.49 per share in its upcoming report, which represents a year-over-year change of +9.8%. The consensus EPS estimate for the quarter has been revised 0.6% higher over the last 30 days to the current level.
Linde's revenues are expected to be $8.96 billion, up 5.5% from the year-ago quarter.
For the quarter ended June 2026, MGIC Investment (MTG - Free Report) reported revenue of $297.61 million, down 2.6% over the same period last year. EPS came in at $0.87, compared to $0.82 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $298.54 million, representing a surprise of -0.31%. The company delivered an EPS surprise of +17.57%, with the consensus EPS estimate being $0.74.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how MGIC performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
GAAP loss ratio (insurance operations only): 4.6% versus 16.6% estimated by two analysts on average.Combined Ratio - Insurance Segment (Net of underwriting expense ratio and Loss ratio): 24.4% versus 38.4% estimated by two analysts on average.GAAP underwriting expense ratio (insurance operations only): 19.8% versus the two-analyst average estimate of 21.9%.Revenues- Net investment income: $59.47 million compared to the $60.69 million average estimate based on two analysts. The reported number represents a change of -2.5% year over year.Revenues- Net premiums earned: $238.06 million compared to the $237.53 million average estimate based on two analysts. The reported number represents a change of -2.6% year over year.Revenues- Other revenue: $0.09 million versus $0.41 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -74% change.View all Key Company Metrics for MGIC here>>>
Shares of MGIC have returned +8.4% over the past month versus the Zacks S&P 500 composite's +1.9% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
C.H. Robinson Worldwide, Inc. (CHRW) Q2 2026 Earnings Call July 29, 2026 5:30 PM EDT
Company Participants
Charles Ives - Senior Director of Investor Relations
David Bozeman - President, CEO & Director
Michael Castagnetto - President of North American Surface Transportation
Arun Rajan - Chief Strategy & Innovation Officer
Damon Lee - Chief Financial Officer
Conference Call Participants
Thomas Wadewitz - UBS Investment Bank, Research Division
Jeffrey Kauffman - Citizens JMP Securities, LLC, Research Division
Ken Hoexter - BofA Securities, Research Division
Bascome Majors - Stephens Inc., Research Division
Scott Group - Wolfe Research, LLC
Jonathan Chappell - Evercore ISI Institutional Equities, Research Division
Stephanie Benjamin Moore - Jefferies LLC, Research Division
Richa Talwar - Deutsche Bank AG, Research Division
Presentation
Operator
Good afternoon, ladies and gentlemen, and welcome to the C.H. Robinson Second Quarter 2026 Conference Call. [Operator Instructions] As a reminder, this conference is being recorded Wednesday, July 29, 2026.
I would now like to turn the conference over to Chuck Ives, Senior Director of Investor Relations.
Charles Ives
Senior Director of Investor Relations
Thank you, operator, and good afternoon, everyone. On the call with me today is Dave Bozeman, our President and Chief Executive Officer; Michael Castagnetto, our President of North American Surface Transportation; Arun Rajan, our Chief Strategy and Innovation Officer; and Damon Lee, our Chief Financial Officer.
I'd like to remind you that our remarks today contain forward-looking statements. Slide 2 in today's presentation list factors that could cause our actual results to differ from management's expectations.
Our earnings presentation slides are supplemental to our earnings release and can be found in the Investors section of our website at investor.chrobinson.com.
Today's remarks also contain certain non-GAAP measures, and reconciliations of those measures to GAAP measures are included in the presentation.
PennyMac Financial (PFSI - Free Report) came out with quarterly earnings of $1.39 per share, missing the Zacks Consensus Estimate of $2.08 per share. This compares to earnings of $1.02 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -33.17%. A quarter ago, it was expected that this mortgage banking and investment management company would post earnings of $2.22 per share when it actually produced earnings of $2.19, delivering a surprise of -1.35%.
Over the last four quarters, the company has surpassed consensus EPS estimates just once.
PennyMac, which belongs to the Zacks Financial - Mortgage & Related Services industry, posted revenues of $497 million for the quarter ended June 2026, missing the Zacks Consensus Estimate by 7.18%. This compares to year-ago revenues of $444.73 million. The company has topped consensus revenue estimates just once over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
PennyMac shares have lost about 35% since the beginning of the year versus the S&P 500's gain of 8.5%.
What's Next for PennyMac?While PennyMac has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for PennyMac was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #5 (Strong Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $2.49 on $590.97 million in revenues for the coming quarter and $9.77 on $2.29 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Financial - Mortgage & Related Services is currently in the bottom 15% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
UWM Holdings Corporation (UWMC - Free Report) , another stock in the same industry, has yet to report results for the quarter ended June 2026.
This company is expected to post quarterly earnings of $0.09 per share in its upcoming report, which represents a year-over-year change of -43.8%. The consensus EPS estimate for the quarter has been revised 20% lower over the last 30 days to the current level.
UWM Holdings Corporation's revenues are expected to be $871.62 million, up 14.9% from the year-ago quarter.
Arm Holdings plc (ARM) Q1 2027 Earnings Call July 29, 2026 5:00 PM EDT
Company Participants
Ian Thornton - Vice President of Investor Relations
Rene Haas - CEO & Director
Jason Child - Executive VP & CFO
Conference Call Participants
Joseph Quatrochi - Wells Fargo Securities, LLC, Research Division
Sebastien Cyrus Naji - William Blair & Company L.L.C., Research Division
Gary Mobley
Thomas O'Malley - Barclays Bank PLC, Research Division
Vivek Arya - BofA Securities, Research Division
Vijay Rakesh - Mizuho Securities USA LLC, Research Division
Yu Shi - Needham & Company, LLC, Research Division
Kinney Chin - TD Cowen, Research Division
Timm Schulze-Melander - Rothschild & Co Redburn, Research Division
Presentation
Operator
Good day and thank you for standing by. Welcome to the Arm First Quarter Fiscal Year 2027 Webcast and Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Ian Thornton, Vice President of Investor Relations.
Ian Thornton
Vice President of Investor Relations
Thank you, and welcome to our first quarter fiscal '27 earnings call. On the call are Rene Haas, Arm's Chief Executive Officer; and Jason Child, Arm's Chief Financial Officer. Today's call contains forward-looking information about the company and its financial results. While these statements represent our best current judgment, our business is subject to many risks and uncertainties that could cause actual results to differ materially.
Important risk factors that may affect our business and future financial results are described in our annual report on Form 20-F filed with the SEC. Arm assumes no obligation to update any forward-looking statements. We will also refer to non-GAAP financial measures.
Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP measures can be found in our shareholder letter as can a discussion of certain projected
Viking Therapeutics vykázala za druhé čtvrtletí čistou ztrátu 128,1 mil. USD, tedy 1,10 USD na akcii, proti 65,6 mil. USD před rokem. Firma zároveň pokračuje v posunu programu VK2735 do fáze III a disponuje 502 mil. USD v hotovosti, peněžních ekvivalentech a krátkodobých investicích.
Viking Therapeutics Faces Timeline Risk—But Upside Could Be HugeViking Therapeutics NASDAQ: VKTX reported a wider second-quarter loss as the company increased spending to advance its obesity pipeline, including its lead dual GLP-1/GIP receptor agonist, VK2735, through Phase III development in injectable and planned oral formulations.
The company reported a net loss of $128.1 million, or $1.10 per share, for the three months ended June 30, compared with a net loss of $65.6 million, or $0.58 per share, a year earlier. Research and development expense rose to $115.8 million from $60.2 million, driven primarily by clinical-study costs, employee compensation, stock-based compensation and third-party consultants. General and administrative expense increased to $16.9 million from $14.4 million.
Get Viking Therapeutics alerts:
3 Companies at the Forefront of the GLP-1 Pill WarsFor the first six months of 2026, Viking reported a net loss of $286.5 million, or $2.47 per share, versus a loss of $111.2 million, or $0.99 per share, in the prior-year period. The company ended the quarter with $502 million in cash, cash equivalents and short-term investments, down from $706 million at Dec. 31, 2025.
VK2735 Phase III Trials Fully Enrolled President and Chief Executive Officer Brian Lian said Viking’s Phase III VANQUISH program for subcutaneous VK2735 continued to progress as planned during the quarter. Both trials are fully enrolled.
Viking Therapeutics: The High-Stakes Weight Loss ContenderVANQUISH 1 is studying VK2735 in adults with obesity and enrolled about 4,500 participants by November 2025. VANQUISH 2, which is studying adults with obesity and type 2 diabetes, enrolled about 1,000 participants and completed enrollment in the first quarter of 2026.
The randomized, double-blind, placebo-controlled studies are evaluating once-weekly subcutaneous doses of 7.5 milligrams, 12.5 milligrams and 17.5 milligrams over 78 weeks. The primary endpoint is the percentage change in body weight from baseline compared with placebo. Secondary and exploratory measures include the proportions of patients achieving at least 5%, 10%, 15% and 20% weight loss.
Each VANQUISH study also includes an extension period in which participants may continue treatment, including participants initially assigned to placebo.
Lian cited prior Phase II results from the VENTURE study, where weekly VK2735 produced mean body-weight reductions of up to 14.7% after 13 weekly doses, with no signs of a plateau, according to the company. Viking said the treatment was generally well tolerated in that study, with most treatment-emergent adverse events described as mild or moderate.
Oral Program Planned for Fourth Quarter Viking continues preparations to begin a Phase III program for its oral tablet formulation of VK2735 in the fourth quarter. Lian said the oral program will include two trials that generally mirror the injectable VANQUISH program, though the studies are expected to be smaller and shorter in duration.
In Phase II testing of oral VK2735, participants receiving once-daily tablets achieved mean body-weight reductions of up to 12.2% after 13 weeks, Viking said. The company reported that all doses above 15 milligrams showed statistically significant differences versus both baseline and placebo beginning at week one. Up to 80% of subjects in treatment groups achieved at least 10% weight loss, compared with 5% of placebo-treated subjects.
Lian said the company expects to disclose full details of the Phase III oral program, including dose selection, when the trials are initiated. He said Viking believes the program could position VK2735 as the first oral dual GLP-1/GIP agonist to reach the market, if successful.
Maintenance-Dosing Data Expected This Quarter Viking also expects to report results later this quarter from a maintenance-dosing study of injectable VK2735. The study is evaluating weekly, every-other-week and monthly regimens following an initial weekly treatment period.
The study is designed to assess safety, tolerability and pharmacokinetics, while exploratory endpoints include changes in body weight from baseline and during the maintenance period. Lian said the trial is nearing completion and could help guide dose selection for VANQUISH extension studies expected to start in late 2026 or early 2027.
During the question-and-answer session, Lian said Viking would aim to provide separate tolerability data for the initial induction period and the maintenance period, though granular weekly data may not be available with the initial topline release. The company uses a compressed titration schedule in the maintenance study to reach the maintenance phase sooner than it would with less-frequent dosing from the outset.
After the injectable maintenance cohorts are completed, Viking plans to continue the study with oral maintenance regimens. That portion is expected to conclude in the first half of 2027.
Earlier-Stage Obesity Pipeline Expands During the quarter, Viking began a Phase I single-ascending-dose trial of VK3019, an investigational dual amylin and calcitonin receptor agonist for obesity. The randomized, double-blind, placebo-controlled study is enrolling healthy adults with a body mass index of at least 27 and is evaluating the safety, tolerability and pharmacokinetics of single subcutaneous doses.
Lian said Viking views VK3019 as having potential both as a standalone treatment and, potentially, in combination with VK2735. However, he said decisions about advancing the program will require data from a multiple-ascending-dose Phase I study, which the company expects to have in the 2027 timeframe. A combination product would not enter clinical testing before next year at the earliest, he said.
The company also expanded its leadership and commercial infrastructure. Viking appointed Neil Aubuchon as chief commercial officer in the first quarter, named Hubert Chen, M.D., chief medical officer during the second quarter, and subsequently appointed Dorothy Gemmell to its board of directors.
Management said it expects cash use to taper from the current period as the company moves beyond the heaviest spending phase of its subcutaneous Phase III trials. Viking reiterated that it expects its cash position to fund operations into 2028.
About Viking Therapeutics (NASDAQ:VKTX)Viking Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders. Headquartered in San Diego, California, the company's pipeline leverages small-molecule approaches to target hormone signaling pathways implicated in conditions such as non‐alcoholic steatohepatitis (NASH), dyslipidemia, type 2 diabetes and muscle wasting disorders.
The company's lead programs include VK2809, a thyroid hormone receptor‐beta agonist designed to reduce liver fat and improve lipid profiles in patients with NASH and dyslipidemia, and VK5211, a selective androgen receptor modulator (SARM) aimed at enhancing muscle mass and function in individuals with muscle wasting conditions.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in Viking Therapeutics Right Now?Before you consider Viking Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Viking Therapeutics wasn't on the list.
While Viking Therapeutics currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Viking Therapeutics uspořádala konferenční hovor k hospodářským výsledkům za 2. čtvrtletí 2026. Společnost zároveň upozornila na výhled, časové plány a milníky.
Viking Therapeutics, Inc. (VKTX) Q2 2026 Earnings Call July 29, 2026 4:30 PM EDT
Company Participants
Stephanie Diaz
Brian Lian - President, CEO & Director
Gregory Zante - Chief Financial Officer
Conference Call Participants
Steven Seedhouse - Cantor Fitzgerald & Co., Research Division
Ryan Deschner - Raymond James & Associates, Inc., Research Division
Michael Ulz - Morgan Stanley, Research Division
Hardik Parikh - JPMorgan Chase & Co, Research Division
Biren Amin - Piper Sandler & Co., Research Division
Tsan-Yu Hsieh - William Blair & Company L.L.C., Research Division
Annabel Samimy - Stifel, Nicolaus & Company, Incorporated, Research Division
Jay Olson - Oppenheimer & Co. Inc., Research Division
Yale Jen - Laidlaw & Company (UK) Ltd., Research Division
Fiona Shang - Jefferies LLC, Research Division
William Wood - B. Riley Securities, Inc., Research Division
Jeet Mukherjee - BTIG, LLC, Research Division
Gregory Renza - Truist Securities, Inc., Research Division
Daniel Brims - Lake Street Capital Markets, LLC, Research Division
Presentation
Operator
Good day, and welcome to the Viking Therapeutics Second Quarter 2026 Financial Results Conference Call. [Operator Instructions] And as a reminder, this conference call is being recorded today, July 29, 2026. I would now like to turn the conference over to Viking's Manager of Investor Relations, Stephanie Diaz. Please go ahead, Stephanie.
Stephanie Diaz
Hello, and thank you all for participating in today's call. Joining me today is Brian Lian, Viking's President and CEO; and Greg Zante, Viking's CFO. Before we begin, I'd like to caution that comments made during this conference call today, July 29, 2026, will contain forward-looking statements under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including statements about Viking's expectations regarding its development activities, time lines and milestones.
Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially and adversely, and reported results should not be
Farmland Partners (FPI - Free Report) came out with quarterly funds from operations (FFO) of $0.04 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to FFO of $0.03 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an FFO surprise of +33.33%. A quarter ago, it was expected that this real estate investment trust specializing in farmland would post FFO of $0.04 per share when it actually produced FFO of $0.05, delivering a surprise of +25%.
Over the last four quarters, the company has surpassed consensus FFO estimates four times.
Farmland Partners, which belongs to the Zacks REIT and Equity Trust - Other industry, posted revenues of $9.4 million for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 3.04%. This compares to year-ago revenues of $9.96 million. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future FFO expectations will mostly depend on management's commentary on the earnings call.
Farmland Partners shares have lost about 1.4% since the beginning of the year versus the S&P 500's gain of 8.5%.
What's Next for Farmland Partners?While Farmland Partners has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's FFO outlook. Not only does this include current consensus FFO expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Farmland Partners was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus FFO estimate is $0.05 on $9.8 million in revenues for the coming quarter and $0.31 on $44.69 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, REIT and Equity Trust - Other is currently in the top 25% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, Apple Hospitality REIT (APLE - Free Report) , is yet to report results for the quarter ended June 2026. The results are expected to be released on August 5.
This hotel-owning real estate investment trust is expected to post quarterly earnings of $0.50 per share in its upcoming report, which represents a year-over-year change of +6.4%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Apple Hospitality REIT's revenues are expected to be $398.5 million, up 3.7% from the year-ago quarter.
Sturm, Ruger & Company uvedla, že ve 2. čtvrtletí dosáhla silných finančních výsledků a pokročila v plánu pro rok 2026. Firma také zlepšila výrobní výkon.
Sturm, Ruger & Company, Inc. (RGR) Q2 2026 Earnings Call July 29, 2026 4:30 PM EDT
Company Participants
Todd Seyfert - President, CEO & Director
Sarah Colbert - SVP, VP of Administration, General Counsel & Corporate Secretary
Conference Call Participants
Mark Smith - Lake Street Capital Markets, LLC, Research Division
Rommel Dionisio - Aegis Capital Corporation, Research Division
Presentation
Operator
Hello everyone, thank you for joining us and welcome to the Sturm, Ruger & Company Q2 Earnings Call. [Operator Instructions]
I will now hand the conference over to Todd Seyfert, CEO. Please go ahead.
Todd Seyfert
President, CEO & Director
Good afternoon, and thank you for joining us for the Sturm, Ruger & Company's Second Quarter 2026 Earnings Conference Call. I'm Todd Seyfert, President and Chief Executive Officer. Before we get started, I would like to turn it over to Sarah Colbert, our General Counsel, for the caution on forward-looking statements.
Sarah Colbert
SVP, VP of Administration, General Counsel & Corporate Secretary
I'd like to remind everyone that some of the statements we make today will be forward-looking in nature. These statements reflect our current expectations, but actual results could differ materially due to several uncertainties and risks. You can find more information about these factors in our most recent Form 10-K and other filings with the SEC. We do not undertake any obligation to update these forward-looking statements. Reconciliations of any non-GAAP measures discussed today are available in our earnings release and on our website.
Todd Seyfert
President, CEO & Director
Thank you, Sarah. As you saw in today's earnings release, the second quarter represented another meaningful step forward in executing our 2026 plan. We delivered another quarter of strong financial results while making meaningful progress in strengthening the foundation of the business. We improved our manufacturing performance and formally established the Ruger Business
Přední demokrat ve Výboru Sněmovny reprezentantů pro energetiku a obchod Frank Pallone vyzval Elona Muska, aby umožnil kontrolu datových center xAI v Memphisu. Žádá informace do 11. srpna kvůli dopadům na cenu elektřiny a životní prostředí.
The top Democrat on the House Committee on Energy and Commerce is demanding that SpaceX CEO Elon Musk provide a tour of his company's xAI data centers and power plants in and around Memphis, Tennessee.
"Americans are concerned about what data centers and Big Tech's push for more AI means for their communities, jobs, property values, and future," Rep. Frank Pallone (D-NJ) wrote in a letter to Musk on Wednesday. "Electricity prices are skyrocketing, the electric grid is strained, our clean air and water are being polluted, and noise is wearing on communities' health and patience."
Public opposition to data centers is rising in the U.S. after xAI's buildout in Memphis, and with others underway from OpenAI, Meta, Microsoft and Google. Gallup found in a survey published in May that seven in 10 Americans oppose the construction of an AI data center in their local area, with 48% strongly opposed.
Pallone has demanded information about Musk's facilities by Aug. 11.
SpaceX didn't respond to a request for comment.
SpaceX's artificial intelligence facilities, known as Colossus and Colossus 2, include three data centers packed with cutting-edge Nvidia processors. They were built by xAI, before SpaceX acquired Musk's startup, which is the developer of Grok's AI models, chatbot and image editing tools.
The facilities are at the heart of SpaceX's AI ambitions, as the company tries to compete with the likes of OpenAI and Anthropic, and to eventually build orbital data centers.
Pallone excoriated SpaceX and Musk for a "disregard for the health and well-being of local communities." He said the company has created "a massive health risk" to neighbors by "trucking in off-grid gas turbines" to power the facilities, all without the proper permits and pollution controls.
President Trump's Department of Justice has filed a motion to intervene, and to effectively help xAI fight off a lawsuit, which was filed by environmental advocates and the NAACP in Mississippi to stop the company's use of allegedly illegal, air-polluting turbines.
"The Trump Administration has essentially claimed that it alone decides whether SpaceXAI and other companies get a free pass to pollute unimpeded," Pallone wrote. "But just because the Trump Administration will bend over backward to give tech companies free rein over community air, water, and land does not make your actions legal."
New Jersey Gov. Mikie Sherrill, a Democrat, enacted legislation earlier this month to ensure data center operators pay a fair share for electricity, instead of shifting costs to residents and businesses.
Mark Zuckerberg řekl, že během pěti let budou mít miliardy lidí osobního AI agenta, který bude pracovat 24/7 na jejich cílech. Meta už nasazuje firemní agenty pro více než milion podniků na WhatsAppu a Messengeru.
A day after blasting OpenAI and Anthropic for hoarding information, the drama surrounding Meta’s Q2 earnings call centered around how he would follow up. Listeners didn’t have to wait long for the answer.
“It’s extremely unlikely, if you look out five years from now, that you don’t have billions of people with a personal agent that understands your goals,” Meta CEO Mark Zuckerberg said on the company’s second quarter earnings call Wednesday (July 29), describing software “working on your behalf 24/7” across health, finances, relationships and careers.
That vision, for every one of Meta’s 3.6 billion daily users to have an assistant that never clocks out dominated Meta’s earnings call. Zuckerberg spent his opening remarks describing a future where personal agents handle everything from health to finances, and the rest of the call built directly on that premise: how Meta pays for it, what stands in the way, and why the company believes it will win anyway.
The vision runs into a hard constraint almost immediately: supply. “There’s just nowhere near enough compute for all the demand,” Zuckerberg said, explaining that Meta is fielding offers to sell its own capacity at a premium but prefers to build intelligence on top of it instead, where the margins run higher.
That scarcity is why Meta is racing to stand up the agent layer now, even in pieces. Meta Superintelligence Labs shipped its Muse Spark 1.1 and Muse Image models this quarter, and daily interactions with the Meta AI assistant have climbed sharply since it’s rebuild. Business agents are already live for more than a million businesses on WhatsApp and Messenger, handling customer inquiries and completed sales without a person in the loop.
Zuckerberg pointed to Brazilian rental company Movida as the model he wants to replicate: a WhatsApp agent that runs the entire booking flow start to finish, resolving the vast majority of conversations without human help. That is the pattern Meta is betting will scale to billions of people next.
Zuckerberg’s Case for Why Meta Wins the AI Bet Scarce compute raises an obvious question: Why should Meta, rather than a rival, end up owning this? Zuckerberg’s answer rests on distribution and the flywheel it creates. “When we have a product and a format that works, I would go as far as to say that I think we’re probably the best company in the world at scaling those experiences to billions of people,” he said, describing how usage data feeds back into the models that improve the products.
He did not pretend the wager was small. “I get that this is a big investment and it’s a big bet,” Zuckerberg said. “My personal bet is that the people who invest in this are going to be rewarded and feel very good over time.”
That confidence is the thesis the entire call built toward: an ad business strong enough to fund an all-in push into personal agents, aimed at a future Zuckerberg is convinced is coming regardless of who builds it.
What Else Stood Out Meta hired Kunal Shah, founder of Indian payments company CRED, as its new head of WhatsApp. Zuckerberg said Shah built one of India’s largest payment companies. Instagram reached 2 billion daily active users. Threads crossed 500 million monthly actives, which Zuckerberg called the fastest-growing conversation app ever. WhatsApp peaked at 30 million messages sent per second during the World Cup final, an all-time record for the platform. AI-driven ranking improvements increased ad clicks and conversions across Meta’s platforms. Advantage+ automated campaigns continue to scale as a core part of ad delivery Meta launched Meta One, a new subscription offering more tools and AI features across its apps, with plans to add further tiers and pricing options Zuckerberg revealed that every public Reels and Feed post on Instagram is now automatically run through an LLM and analyzed across dimensions like topic and tone, a milestone the company hit this year. Topline Growth and Future Outlook Meta reported total revenue of $60.8 billion for the quarter, up 28% year over year, with advertising revenue of $59.4 billion, up 27%. Ad impressions grew 14% and the average price per ad rose 12%. Family of apps other revenue crossed $1 billion for the first time, up 73%.
Capital expenditures for the quarter reached $31.1 billion, while free cash flow came in at $784 million. Meta ended the quarter with $90.3 billion in cash and marketable securities against $83.7 billion in debt, and headcount stood at roughly 75,000, down 3%, reflecting about 8,000 employees affected by May’s reduction.
Looking ahead, Meta guided to third-quarter 2026 revenue of $61 billion to $64 billion, full-year 2026 expenses of $165 billion to $169 billion, and full-year 2026 capital expenditures of $130 billion to $145 billion, with the floor raised from its prior outlook.
The company did not provide specific guidance for 2027 capex.
Meta zvažuje, zda část své AI výpočetní kapacity zpeněžit, nebo si ji ponechat pro vlastní modely. Zuckerberg řekl, že nabídky na compute přicházejí s výraznou prémií.
As Meta gobbles up land to construct massive AI data centers, CEO Mark Zuckerberg says there's a balancing act when it comes to deciding whether to sell excess capacity or to preserve it.
Among the four major U.S. hyperscalers, Meta is the only one that doesn't have a business selling cloud infrastructure and services even though its capital expenditures rival that of its peers. But in recent months, Zuckerberg has been floating the possibility of launching a cloud business as a way to take advantage of its capacity stockpile in a resource-constrained market.
As CNBC reported earlier this month, Anthropic is in preliminary talks to lease computing power from Meta.
"We're getting a lot of offers for compute at a significant premium over what we paid for it," Zuckerberg said on the company's second-quarter earnings call after the bell on Wednesday. "And we have more coding and productivity tools on our roadmap as well."
Zuckerberg's comments came after Meta issued a weaker-than-expected revenue forecast for the third quarter and said free cash flow dwindled by 90% from a year earlier due to soaring capex. The stock sank more than 7% in after-hours trading, extending a slump that's pushed it down 11% for the year as of Wednesday's close.
watch now
In the report, Meta bumped up the low end of its 2026 capital expenditure guidance by $5 billion, bringing the range to between $130 billion and $145 billion. Last week, Alphabet hiked the top end of its guidance to $205 billion and turned cash flow negative for the first time. And Microsoft said in its earnings report on Wednesday that capex for the year will be roughly $175 billion. Amazon reports results on Thursday.
Investors have been seeking details on Zuckerberg's AI strategy, which has been scattershot and left Meta behind OpenAI, Anthropic and Google in the market for top models and services.
"I think everyone wants clarity into what he wants to do in the compute business," Brent Thill, an analyst at Jefferies, told CNBC's "Closing Bell Overtime."
Considering the trade-offZuckerberg offered little by way of specifics on his plans, but he spelled out some of the various considerations at play.
"In terms of running the business, obviously, a common trade-off that we need to make is around how much do you monetize something today versus develop future assets," Zuckerberg said. "I think that it's always a portfolio."
He said that in looking at a potential enterprise business, it's not just about selling capacity. The company also has API and productivity services it can offer as well as AI agents that it's building, Zuckerberg said.
"And I think that there's just a very, very large opportunity there," he said.
However, Meta needs ample compute capacity to satisfy its own AI ambitions, especially as the company begins aggressively rolling out new models under the leadership of AI chief Alexandr Wang. Earlier this month, Meta debuted the Muse Spark 1.1 model, which Wang said represents the "strongest model for agentic and coding work yet" and at a cheaper price than offerings from OpenAI and Anthropic.
"It would be foolish to basically just sell all of the compute and take a short-term profit," Zuckerberg said.
Zuckerberg acknowledged that jumping into the enterprise, where Meta has historically struggled, will require some hard work, and that the company has to learn how to do it. While he didn't reference hiring a sales force, it will be an essential move if Meta is serious about selling to businesses big and small.
"That's going to be somewhat a new muscle that we build as a company," Zuckerberg said. "But I think it's a very important one that we build."
Dave Brown, a former longtime senior executive at Amazon Web Services, is set to join the company, CNBC recently confirmed.
A big challenge for Zuckerberg as he tries to sell Wall Street on his vision is his spotty track record. Zuckerberg's most notable whiff was the metaverse, and his effort starting in 2021 to reshape the company around a futuristic digital world.
That project is still costing Meta billions of dollars a quarter. Meta's Reality Labs, which develops virtual reality devices and wearables, lost $4.62 billion in the latest period on just $431 million of revenue.
Still, Meta is desperate to diversify its business beyond digital ads, which still account for 98% of the company's revenue, and to show that it can be an influential player in AI.
Zuckerberg is all-in.
"I get that this is sort of a big bet across the industry," Zuckerberg said. "My personal bet is that the people who invest in this are going to be rewarded and feel very good over time."
WATCH: Jefferies' Brent Thill: Meta report was 'trifecta' of things that could go wrong.
Mark Zuckerberg uvedl, že globální čas strávený na Instagramu ve čtvrtletí meziročně vzrostl o dvouciferné procento, hlavně díky vylepšením feedu a doporučením pro Reels. Meta zároveň uvedla, že doporučení jsou stále více personalizovaná.
CEO Mark Zuckerberg said that global time spent on Instagram grew by double digits year over year this quarter. Beata Zawrzel/NurPhoto via Getty Images If you can't seem to get off your Instagram scroll, it is not an accident.
During Meta's second-quarter earnings call on Wednesday, CEO Mark Zuckerberg said that global time spent on Instagram grew by double digits year over year this quarter, "largely driven by improvements to our feed and Reels recommendations."
"Our recommendations are also becoming more personalized, surfacing more fresh content while giving people more direct control over what they see," Zuckerberg said, adding that Instagram reels combined "faster inference with a new architecture that draws on deeper user history to improve predictions."
"This drove a 15 basis point increase in sessions on Instagram, with particular strength in reshares and time spent, which are both strong indicators of better content-to-user matching," Zuckerberg added.
According to Zuckerberg, recommendations are trained through automatically feeding every public Reel and post on Instagram to an LLM and analyzing them for topics and tone, which he called "a key building block toward greater personalization."
"And we're working towards including more surfaces on Facebook as well," Zuckerberg said.
Zuckerberg's comments came weeks after the company launched Muse Image in early July, which lets users create AI-generated images from photos on public Instagram accounts of people over 18. By default, eligible public accounts were included without prior notice, triggering a privacy backlash that led to the generation function being shut down in less than a week.
Users could prevent Meta's AI from accessing visual content by going to Instagram's Settings, opening the Share and Reuse section, and switching off the option that lets Meta access photos and videos. There was no such option for text, comments, or audio.
The algorithms have been central to multiple lawsuits filed by more than two dozen states that alleged that Meta designed its products to be addictive to teenagers and children.
During the call, Meta CFO Susan Li said the company expects continued "scrutiny on youth-related issues in several markets" and has "a number of youth-related trials scheduled for this year," which could result in financial losses. The company reported $2.40 billion of charges "related to legal proceedings."
Meta did not immediately respond to a request for comments.
Read next
Katherine Li You're currently following this author! Want to unfollow? Unsubscribe via the link in your email.
Microsoft otevřeně tlačí vlastní AI modely jako levnější alternativu k OpenAI a Anthropic a tvrdí, že firmy nemají spoléhat na jediný model. Nadella zároveň uvedl, že Microsoft nabízí v cloudu více než 11 000 modelů.
Microsoft is in a unique position as AI overtakes the tech industry. It’s one of the world’s largest cloud providers and software-as-a-service companies, while also holding valuable stakes in the two biggest AI labs, OpenAI and Anthropic.
Those incentives are starting to clash as Microsoft posts blockbuster financial results. The company just reported an extremely profitable quarter with $90 billion in revenue and net income of $35.8 billion. For the fiscal year, which ended June 30, Microsoft reported $331.8 billion in revenue with a net income of $133.7 billion for the year.
And CEO Satya Nadella is not about to let the trajectory of Anthropic and OpenAI — which are expanding into applications and agentic infrastructure that could ultimately let them own customer relationships — derail that kind of cash.
Nadella has been preaching to enterprises to use multiple models and to stop relying on the frontier AI labs for the agentic harness/app layer.
Doing so is dangerous, he’s been saying, because it requires companies to share too many of their internal secrets with model makers of dubious trustworthiness. He knows his customers. Enterprise IT fears both data leaks and being locked into a vendor.
Now he has openly told Wall Street analysts during the company’s quarterly conference call Wednesday that this is an opportunity for Microsoft to sell customers its own homegrown models, alongside agents, AI security and more, while promising lower costs.
In other words, he’s pitching Microsoft as an alternative to many of the upscale services that OpenAI and Anthropic are developing for their own growth.
When UBS analyst Karl Keirstead specifically asked Nadella to weigh in on the open vs. closed-sourced debate roiling the AI industry, and how Microsoft will benefit from it, Nadella came out swinging.
“The goal is to have the firm be in control of their own destiny,” the CEO said of enterprises. “We are very, very clear about the architectural sort of design of the platform, which is you got to keep your harness separate from the model … that means any model at any given time is swappable.”
Microsoft, of course, sells a menu of harnesses (aka AI agents), too, under the Copilot name, including its coding agent GitHub Copilot. Coding agents are where much of the AI dollars are being spent today.
And he used the high-profile incident from last week as proof of his warnings.
“If you look even at the Hugging Face incident, the biggest thing that we should take away from that is you can’t sort of depend on any one model,” Nadella said. “You will maybe need multiple models to even remediate some challenges that get caused by one model. Like that’s the way to think about it, right? Which is you can’t be subject to a refusal of one model.”
The incident involved an unreleased model from OpenAI breaking out of its sandbox and successfully mounting a full-scale hack on Hugging Face, all in pursuit of besting a benchmark. Trying to understand what happened, Hugging Face at first tried to use a private frontier model (which it hasn’t named) that refused to help it. So it turned to the Chinese open-source model Z.ai GLM 5.2 to analyze logs and defend its infrastructure. The incident has so shocked the industry that even Sam Altman is now saying that maybe AI development should slow down a bit.
Nadella also made clear that Microsoft is happily selling its own homegrown models, the MAI family, on its own homegrown AI chips, Maya, and pitching them as cheaper alternatives.
“Every customer wants the right model for each task based on quality, latency, cost, and compliance. We offer the broadest model catalog in the cloud with over 11,000 models, including the leads from OpenAI, Anthropic, Mistral, xAI, as well as our own MAI family,” he said.
He added: “We’re also accelerating our own model development. We announced more than a dozen new models across image, voice, transcription, coding, security, including our first reasoning model, MAI thinking one, all with cost-efficient inference at the core for the enterprise use cases. We are co-designing these models with our silicon, and we are seeing 40% better performance per watt when running MAI models on Maya 200.”
As for Mythos? Nadella pointed to Microsoft’s new Mythos competitor announced earlier this week, MAI Cyber One Flash. It “achieves better performance than the much larger Mythos model, but at half the cost when combined with our multi-agent security harness,” he said.
Sure, the Microsoft CEO says that enterprises should use the frontier models that OpenAI and Anthropic offer in their mix. But his bigger message is: don’t trust them enough to rely on them.
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.
Microsoft prodlouží odhadovanou životnost datacenter a kancelářských budov z 15 na 25 let, aby zmírnil dopad vysokých kapitálových investic do AI. Kapitálové investice ve čtvrtletí vzrostly o 70 % na 41,0 miliardy USD.
Microsoft reported strong growth in its cloud and artificial intelligence businesses while also working to moderate the impact of capital expenditures.
The company said in a Wednesday (July 29) earnings release that during the quarter ended June 30, its Intelligent Cloud revenue increased 32% year over year to $39.3 billion, its Productivity and Business Processes revenue rose 14% year over year to $37.8 billion, and its More Personal Computing revenue declined 4% year over year to $12.9 billion.
Overall, Microsoft’s revenue was up 18% year over year to $90.0 billion, according to the release.
Microsoft Chairman and CEO Satya Nadella said in the earnings release that customers’ confidence in Microsoft’s AI offerings was reflected by Azure revenue topping $100 billion for the first time and Microsoft 365 Copilot surpassing 30 million paid seats.
During a Wednesday earnings call, Nadella said Microsoft 365 Copilot’s net seat adds more than doubled quarter over quarter, the number of conversations per user nearly doubled year over year, and the number of customers with more than 5,000 seats increased seven times year over year.
“NHS England, for example, is rolling out Copilot to 505,000 clinicians and staff, the largest healthcare deployment of its kind, after a trial showed it saved employees an average of 43 minutes per day,” Nadella said during the call.
Microsoft’s capital expenditures increased 70% year over year to $41.0 billion during the most recent quarter, according to a fourth quarter fiscal year 2026 results presentation released Wednesday.
The presentation attributed the increase to supporting customer demand for Microsoft’s cloud and AI offerings as well as the impact of higher component prices.
Microsoft’s capital expenditures expectations for the 2026 calendar year remain unchanged at about $175 billion, while those for full year fiscal 2027 are expected to grow year over year, according to a first quarter fiscal year 2027 outlook presentation released Wednesday.
The outlook presentation said that the expectations for the 2026 calendar year include the impact of a useful life change on future lease classification.
Microsoft Executive Vice President and Chief Financial Officer Amy Hood said during the earnings call that as of the start of fiscal year 2027, the company is extending the estimated useful life of its data centers and office buildings from 15 years to 25.
“The greater impact is on capital expenditures as more of our future data center leases will shift from finance leases to operating leases,” Hood said. “As a result of this update, finance leases are included in capital expenditures while operating leases are not. Outside of this useful life impact, our calendar year 2026 capex investment expectations remain unchanged. However, the shift from finance to operating leases adjusts our expectation to approximately $175 billion.”
Looking ahead, Microsoft expects its total revenue to see double-digit growth during full year fiscal 2027, according to the outlook presentation.
A Sony logo appears in this illustration taken August 25, 2025. REUTERS/Dado Ruvic/Illustration Purchase Licensing Rights, opens new tab
TOKYO, July 30 (Reuters) - Japanese camera lens maker Tamron (7740.T), opens new tab said on Thursday it has received an acquisition proposal from Sony Group (6758.T), opens new tab and that it has established a committee to review its options.
The optical components manufacturer said in a statement that Sony made a non-binding proposal for a series of transactions to turn it into a wholly owned subsidiary.
Make sense of global markets with the Trading Day newsletter. Sign up here.
Tamron's shares were untraded with a glut of buy orders in early Tokyo trade. The company had a market capitalisation of $1.18 billion as at Wednesday's close. Sony's shares were down 1.7%.
A Sony spokesperson said the entertainment and technology conglomerate believes the proposal will enhance Tamron's corporate value and the interests of its stakeholders, and contribute to the development of Sony's imaging business.
Sony is a manufacturer of cameras and image sensors, while Tamron is a supplier of lenses for its cameras as well as for cameras made by Nikon (7731.T), opens new tab and Canon (7751.T), opens new tab.
Sony owns 14.7% of Tamron, LSEG data showed. Singapore-based Effissimo Capital is the largest shareholder with 17.4%.
Shares in Sony have been under pressure in recent months as investors worry about high memory chip prices and the impact of artificial intelligence on its entertainment business.
Reporting by Sam Nussey and Hina Suzuki; Editing by Jacqueline Wong and Christopher Cushing
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Omega Healthcare Investors (OHI - Free Report) came out with quarterly funds from operations (FFO) of $0.83 per share, beating the Zacks Consensus Estimate of $0.8 per share. This compares to FFO of $0.77 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an FFO surprise of +3.75%. A quarter ago, it was expected that this health care real estate investment trust would post FFO of $0.8 per share when it actually produced FFO of $0.82, delivering a surprise of +2.5%.
Over the last four quarters, the company has surpassed consensus FFO estimates four times.
Omega Healthcare Investors, which belongs to the Zacks REIT and Equity Trust - Other industry, posted revenues of $328.25 million for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 3.17%. This compares to year-ago revenues of $282.51 million. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future FFO expectations will mostly depend on management's commentary on the earnings call.
Omega Healthcare Investors shares have added about 16.5% since the beginning of the year versus the S&P 500's gain of 8.5%.
What's Next for Omega Healthcare Investors?While Omega Healthcare Investors has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's FFO outlook. Not only does this include current consensus FFO expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Omega Healthcare Investors was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus FFO estimate is $0.81 on $323.38 million in revenues for the coming quarter and $3.22 on $1.29 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, REIT and Equity Trust - Other is currently in the top 25% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
RLJ Lodging (RLJ - Free Report) , another stock in the same industry, has yet to report results for the quarter ended June 2026. The results are expected to be released on August 6.
This hotel real estate investment trust is expected to post quarterly earnings of $0.49 per share in its upcoming report, which represents a year-over-year change of +2.1%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
RLJ Lodging's revenues are expected to be $363.96 million, up 0.2% from the year-ago quarter.
Beetaloo Energy Australia uzavřela nezávaznou dohodu s Halliburton o podpoře plynového projektu pro datová centra a AI v Severním teritoriu Austrálie. Halliburton má dodat technické know-how pro těžbu a rozvoj plynových zdrojů.
The company logo of Halliburton oilfield services corporate offices is seen in Houston, Texas April 6, 2012. REUTERS/Richard Carson/File Photo Purchase Licensing Rights, opens new tab
CompaniesJuly 30 (Reuters) - Beetaloo Energy Australia (BTL.AX), opens new tab said on Thursday it had signed a non-binding agreement with oilfield services firm Halliburton (HAL.N), opens new tab to help advance a proposed gas-to-power and data centre development in Australia's Northern Territory.
Halliburton will provide technical expertise to assess and develop gas resources for Beetaloo Digital, a project focused on supplying power to hyperscale data centres and AI infrastructure, centred on a 185-hectare site at Weddell near Darwin.
The Reuters Power Up newsletter provides everything you need to know about the global energy industry. Sign up here.
Beetaloo Energy said Halliburton could contribute expertise in field development, drilling, project execution and scalable gas-fired power generation.
Beetaloo Energy Chief Executive Alex Underwood described the agreement as another step in building a group of specialist partners across gas supply, power generation, pipelines and data-centre development.
The project is based on gas resources in the Beetaloo Basin and remains subject to concept studies, partner agreements, financing and regulatory approvals, the company said.
Reporting by Rajasik Mukherjee; Editing by Subhranshu Sahu
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Robinhood ve 2. čtvrtletí vykázal rekordní tržby 1,3 miliardy USD, meziročně o 32 % více, a zároveň zrychluje snahu ovládnout více částí finančních služeb pro zákazníky mimo samotné obchodování.
Robinhood is moving beyond its original role as a retail broker. And that’s despite the fact that the second-quarter 2026 results shared company’s Wednesday (July 29) earnings call looked like a victory for its trading business.
“The business is firing on all cylinders,” said Shiv Verma, chief financial officer of Robinhood. “We delivered record revenues and drove new highs across equity, option, and event contract volumes, as we continue to win market share. Our product velocity continues to deliver new products for customers and drive a more diversified business, with Robinhood Legend and the Credit Card business joining our growing roster of now 13 different business lines that have reached $100 million-plus in annualized revenues.”
Robinhood reported record quarterly revenue of $1.3 billion, up 32% from a year earlier, alongside $22 billion in net deposits and a 57% adjusted EBITDA margin. Activity reached new highs across equities, options and prediction markets, while the company added its strongest quarterly funded customer gain in almost five years to brush up against the 1 million number.
But executives stressed that Robinhood’s next phase is not primarily about processing more trades. Across prediction markets, tokenized assets, banking and credit cards, the financial platform is attempting to control more of the customer relationship and more of the transaction stack beneath it.
See more: How Uncertainty Became the Engagement Engine of the Digital Economy
Robinhood Sees Its Brokerage as an Acquisition Engine Rather than connecting customers to products, exchanges and market makers operated by others, Robinhood executives shared their goal of becoming the system through which customers receive income, spend money, build savings, invest, access credit and eventually delegate financial decisions to artificial intelligence.
A customer might arrive for stocks, options, crypto, retirement accounts, prediction markets, banking or a credit card. Robinhood’s goal is then to convert that customer into a Gold subscriber and introduce additional services.
Management said roughly 40% to 50% of new customers subscribe to Gold, regardless of which product initially brought them to the platform. Customers who use prediction markets, for example, are also more likely to hold Robinhood retirement accounts. The number of customers who have traded prediction-market contracts has grown from about 1.5 million to nearly 2 million.
Robinhood’s credit card has surpassed 1 million cardholders and is generating more than $17 billion in annualized purchase volume. Its banking offering has attracted more than $3 billion in deposits since beginning its rollout in November. Gold membership reached a record 4.8 million subscribers, equal to 17% of funded accounts.
See also: Prediction Markets Turn Uncertainty Into a Business Model
The platform’s prediction-market joint venture, Rothera, became a top-three U.S. designated contract market shortly after launching. The executives on the call said they expect more Robinhood event-contract volume to migrate to the venue as its capacity grows, and suggested that Rothera could eventually support other futures commission merchants, turning prediction markets from a retail feature into a potential infrastructure business.
Robinhood Chain reflects the same ambition in digital assets. Built around tokenized real-world assets, the blockchain generated more than $12 billion in decentralized-exchange volume shortly after launch and became one of the fastest networks to surpass 100 million transactions.
The emerging strategy is straightforward: acquire customers through a growing range of products, move more of their financial lives onto the platform and increasingly own the rails that process their activity.
But adding products is easier than making them feel like one financial experience.
Banking Is Becoming Robinhood’s Funding Layer, but Orchestration Remains Paramount As Robinhood expands, it must decide which services to present to each customer, when to introduce them and how to prevent a growing collection of accounts and applications from becoming confusing.
CEO Vlad Tenev acknowledged that challenge during the earnings call.
“The orchestration of all of these things into one story, into one financial tool, is becoming an increasing source of focus,” he said.
Robinhood’s expansion into banking may prove more important than any individual trading product because it changes how money enters the ecosystem. Robinhood Banking has attracted more than $3 billion in deposits since its rollout began last November. Roughly 40% of banking customers have enrolled in direct deposit.
Robinhood is also preparing for a future in which financial activity is initiated by software agents rather than by customers navigating applications themselves.
Its first agentic trading product lets users connect external AI tools to separate Robinhood accounts and develop strategies involving equities and options, with crypto support planned. More than 100,000 users have opened or integrated agentic accounts, according to management.
The product remains technically demanding. Customers must connect coding-oriented AI systems, and general-purpose models are not always designed to execute trades reliably. But the long-term implication is larger than the current user experience.
The next stage will not be decided by whether Robinhood can launch another popular feature. It will be decided by whether it can make a complex portfolio of products behave like one financial system.
Robinhood Markets, Inc. (HOOD) Q2 2026 Earnings Call July 29, 2026 5:00 PM EDT
Company Participants
Vladimir Tenev - Co-Founder, President, CEO & Chairman of the Board
Shiv Verma - Chief Financial Officer
Chris Koegel - Vice President of Corporate Finance & Investor Relations
Conference Call Participants
Dan Dolev - Mizuho Securities USA LLC, Research Division
Daniel Fannon - Jefferies LLC, Research Division
David Smith - Truist Securities, Inc., Research Division
Devin Ryan - Citizens JMP Securities, LLC, Research Division
Chinedu Bolu - Autonomous Research US LP
Ramsey El-Assal - Cantor Fitzgerald & Co., Research Division
James Yaro - Goldman Sachs Group, Inc., Research Division
Craig Maurer - Financial Technology Partners LP
Amit Kukreja
Steven Chubak - Wolfe Research, LLC
Craig Siegenthaler - BofA Securities, Research Division
Alexander Markgraff - KeyBanc Capital Markets Inc., Research Division
Brian Bedell - Deutsche Bank AG, Research Division
Patrick Moley - Piper Sandler & Co., Research Division
Benjamin Budish - Barclays Bank PLC, Research Division
Edward Engel - Compass Point Research & Trading, LLC, Research Division
Andrew Harte - BTIG, LLC, Research Division
Presentation
Operator
Thank you to everyone for joining Robinhood's Q2 2026 Earnings Call, whether you're tuning into the live stream or here with us in person. With us today are Chairman and CEO, Vlad Tenev; CFO, Shiv Verma; and VP of Corporate Finance and Investor Relations, Chris Koegel. Vlad and Shiv will offer opening remarks and then open the call to Q&A.
During the Q&A portion of the call, we will answer questions from the audience, which includes institutional research analysts, finance content creators who may hold an ownership position in Robinhood, and both institutional and retail shareholders.
As a reminder, today's call will contain forward-looking statements. Actual results could differ materially from our current expectations, and we may not provide updates unless legally required. Potential risk factors that could cause differences, including regulatory developments that we continue to monitor, are described in
Coursera (COUR - Free Report) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.12 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +54.55%. A quarter ago, it was expected that this online learning platform would post earnings of $0.09 per share when it actually produced earnings of $0.07, delivering a surprise of -22.22%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.
Coursera, which belongs to the Zacks Technology Services industry, posted revenues of $298.6 million for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 1.61%. This compares to year-ago revenues of $187.1 million. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Coursera shares have lost about 20.5% since the beginning of the year versus the S&P 500's gain of 8.5%.
What's Next for Coursera?While Coursera has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Coursera was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.19 on $367.82 million in revenues for the coming quarter and $0.59 on $1.23 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Technology Services is currently in the bottom 39% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, Crane NXT (CXT - Free Report) , is yet to report results for the quarter ended June 2026. The results are expected to be released on August 5.
This maker of engineered industrial products is expected to post quarterly earnings of $1.04 per share in its upcoming report, which represents a year-over-year change of +7.2%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Crane NXT's revenues are expected to be $487.97 million, up 20.7% from the year-ago quarter.
Antero Resources (AR - Free Report) came out with quarterly earnings of $0.76 per share, beating the Zacks Consensus Estimate of $0.75 per share. This compares to earnings of $0.35 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +1.33%. A quarter ago, it was expected that this oil and natural gas producer would post earnings of $1.22 per share when it actually produced earnings of $1.15, delivering a surprise of -5.74%.
Over the last four quarters, the company has surpassed consensus EPS estimates just once.
Antero Resources, which belongs to the Zacks Oil and Gas - Exploration and Production - United States industry, posted revenues of $1.56 billion for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 4.41%. This compares to year-ago revenues of $1.3 billion. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Antero Resources shares have lost about 1.7% since the beginning of the year versus the S&P 500's gain of 8.5%.
What's Next for Antero Resources?While Antero Resources has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Antero Resources was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.92 on $1.58 billion in revenues for the coming quarter and $4.16 on $6.77 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Oil and Gas - Exploration and Production - United States is currently in the bottom 13% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, Cheniere Energy (LNG - Free Report) , is yet to report results for the quarter ended June 2026. The results are expected to be released on August 6.
This natural gas company is expected to post quarterly earnings of $2.78 per share in its upcoming report, which represents a year-over-year change of -61.9%. The consensus EPS estimate for the quarter has been revised 1.9% lower over the last 30 days to the current level.
Cheniere Energy's revenues are expected to be $5.03 billion, up 8.4% from the year-ago quarter.
EPR Properties (EPR - Free Report) came out with quarterly funds from operations (FFO) of $1.42 per share, beating the Zacks Consensus Estimate of $1.35 per share. This compares to FFO of $1.24 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an FFO surprise of +5.19%. A quarter ago, it was expected that this real estate investment trust would post FFO of $1.26 per share when it actually produced FFO of $1.26, delivering no surprise.
Over the last four quarters, the company has surpassed consensus FFO estimates three times.
EPR Properties, which belongs to the Zacks REIT and Equity Trust - Retail industry, posted revenues of $169.03 million for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 5.15%. This compares to year-ago revenues of $150.35 million. The company has topped consensus revenue estimates three times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future FFO expectations will mostly depend on management's commentary on the earnings call.
EPR Properties shares have added about 28.9% since the beginning of the year versus the S&P 500's gain of 8.5%.
What's Next for EPR Properties?While EPR Properties has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's FFO outlook. Not only does this include current consensus FFO expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of estimate revisions.
Ahead of this earnings release, the estimate revisions trend for EPR Properties was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus FFO estimate is $1.49 on $167.99 million in revenues for the coming quarter and $5.50 on $649.88 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, REIT and Equity Trust - Retail is currently in the top 23% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Another stock from the same industry, Agree Realty (ADC - Free Report) , has yet to report results for the quarter ended June 2026. The results are expected to be released on July 30.
This real estate investment trust is expected to post quarterly earnings of $1.13 per share in its upcoming report, which represents a year-over-year change of +6.6%. The consensus EPS estimate for the quarter has been revised 0.2% lower over the last 30 days to the current level.
Agree Realty's revenues are expected to be $201.73 million, up 14.9% from the year-ago quarter.
Flowserve (FLS - Free Report) came out with quarterly earnings of $0.95 per share, beating the Zacks Consensus Estimate of $0.86 per share. This compares to earnings of $0.91 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +10.47%. A quarter ago, it was expected that this company that makes pumps, valves and other parts for the oil and gas industries would post earnings of $0.82 per share when it actually produced earnings of $0.85, delivering a surprise of +3.66%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Flowserve, which belongs to the Zacks Manufacturing - General Industrial industry, posted revenues of $1.17 billion for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 0.87%. This compares to year-ago revenues of $1.19 billion. The company has topped consensus revenue estimates just once over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Flowserve shares have added about 5.8% since the beginning of the year versus the S&P 500's gain of 8.5%.
What's Next for Flowserve?While Flowserve has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Flowserve was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.05 on $1.29 billion in revenues for the coming quarter and $4.04 on $4.88 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Manufacturing - General Industrial is currently in the top 21% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Applied Industrial Technologies (AIT - Free Report) , another stock in the same industry, has yet to report results for the quarter ended June 2026. The results are expected to be released on August 13.
This industrial products company is expected to post quarterly earnings of $2.91 per share in its upcoming report, which represents a year-over-year change of +3.9%. The consensus EPS estimate for the quarter has been revised 0.1% higher over the last 30 days to the current level.
Applied Industrial Technologies' revenues are expected to be $1.29 billion, up 5.6% from the year-ago quarter.
Conmed (CNMD - Free Report) came out with quarterly earnings of $1.38 per share, beating the Zacks Consensus Estimate of $1.1 per share. This compares to earnings of $1.15 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +25.46%. A quarter ago, it was expected that this medical technology company would post earnings of $0.82 per share when it actually produced earnings of $0.89, delivering a surprise of +8.54%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Conmed, which belongs to the Zacks Medical - Dental Supplies industry, posted revenues of $343.49 million for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 1.85%. This compares to year-ago revenues of $342.35 million. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Conmed shares have added about 9% since the beginning of the year versus the S&P 500's gain of 8.5%.
What's Next for Conmed?While Conmed has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Conmed was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.05 on $334.99 million in revenues for the coming quarter and $4.38 on $1.36 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Dental Supplies is currently in the top 40% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Dentsply International (XRAY - Free Report) , another stock in the same industry, has yet to report results for the quarter ended June 2026. The results are expected to be released on August 6.
This dental products manufacturer is expected to post quarterly earnings of $0.36 per share in its upcoming report, which represents a year-over-year change of -30.8%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Dentsply International's revenues are expected to be $883.85 million, down 5.6% from the year-ago quarter.
For the quarter ended June 2026, Meritage Homes (MTH - Free Report) reported revenue of $1.4 billion, down 13.8% over the same period last year. EPS came in at $1.42, compared to $2.04 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $1.43 billion, representing a surprise of -1.78%. The company delivered an EPS surprise of +9.23%, with the consensus EPS estimate being $1.30.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Meritage performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Home Closing Revenue - Average sales price - Total: $373.00 versus the nine-analyst average estimate of $377.59.Homes ordered - Total: 3,575 compared to the 3,774 average estimate based on nine analysts.Order Backlog - Total: 1,715 compared to the 1,856 average estimate based on eight analysts.Homes closed - Total: 3,725 compared to the 3,750 average estimate based on eight analysts.Active Communities - Ending - Total: 340 compared to the 351 average estimate based on six analysts.Home Orders - Average sales price - Total: $385.00 versus $379.23 estimated by six analysts on average.Homes Ordered Value - Total: $1.38 billion versus the six-analyst average estimate of $1.43 billion.Order Backlog Value - Total: $661.91 million versus the five-analyst average estimate of $725.24 million.Revenue- Total closing revenue (Homebuilding): $1.4 billion compared to the $1.43 billion average estimate based on nine analysts. The reported number represents a change of -13.8% year over year.Revenue- Home closing: $1.39 billion versus $1.42 billion estimated by nine analysts on average. Compared to the year-ago quarter, this number represents a -14.1% change.Revenue- Land closing: $12.72 million versus the nine-analyst average estimate of $8.5 million. The reported number represents a year-over-year change of +53.7%.Revenue- Financial Services: $7.78 million versus the eight-analyst average estimate of $8.69 million. The reported number represents a year-over-year change of -17.4%.View all Key Company Metrics for Meritage here>>>
Shares of Meritage have returned -12.7% over the past month versus the Zacks S&P 500 composite's +1.9% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
For the quarter ended June 2026, Q2 Holdings (QTWO - Free Report) reported revenue of $219.77 million, up 12.6% over the same period last year. EPS came in at $0.70, compared to $0.50 in the year-ago quarter.
The reported revenue represents a surprise of +1.26% over the Zacks Consensus Estimate of $217.02 million. With the consensus EPS estimate being $0.67, the EPS surprise was +4.48%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Q2 Holdings performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Revenue- Subscription: $182.77 million versus the three-analyst average estimate of $182.12 million.Revenue- Services and other: $19.07 million versus the three-analyst average estimate of $18.62 million.Revenue- Transactional: $17.92 million versus the three-analyst average estimate of $16.23 million.View all Key Company Metrics for Q2 Holdings here>>>
Shares of Q2 Holdings have returned +23.2% over the past month versus the Zacks S&P 500 composite's +1.9% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
In the latest close session, Lennar (LEN - Free Report) was down 3.53% at $84.56. The stock's change was less than the S&P 500's daily loss of 1.52%. Meanwhile, the Dow experienced a drop of 2.19%, and the technology-dominated Nasdaq saw a decrease of 1.74%.
Shares of the homebuilder have depreciated by 3.14% over the course of the past month, outperforming the Construction sector's loss of 8.26%, and lagging the S&P 500's gain of 1.92%.
The upcoming earnings release of Lennar will be of great interest to investors. The company is predicted to post an EPS of $1.31, indicating a 34.5% decline compared to the equivalent quarter last year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $8.33 billion, down 5.42% from the year-ago period.
For the full year, the Zacks Consensus Estimates project earnings of $5.46 per share and a revenue of $32.27 billion, demonstrating changes of -32.26% and -5.6%, respectively, from the preceding year.
Investors might also notice recent changes to analyst estimates for Lennar. Such recent modifications usually signify the changing landscape of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection has moved 1.22% lower. Lennar currently has a Zacks Rank of #5 (Strong Sell).
Investors should also note Lennar's current valuation metrics, including its Forward P/E ratio of 16.06. This valuation marks a premium compared to its industry average Forward P/E of 14.65.
Meanwhile, LEN's PEG ratio is currently 2.94. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. Building Products - Home Builders stocks are, on average, holding a PEG ratio of 2.94 based on yesterday's closing prices.
The Building Products - Home Builders industry is part of the Construction sector. This industry currently has a Zacks Industry Rank of 172, which puts it in the bottom 31% of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
Entergy Corporation (ETR) Q2 2026 Earnings Call July 29, 2026 11:00 AM EDT
Company Participants
Liz Hunter - Vice President of Investor Relations
Andrew Marsh - Chairman of the Board & CEO
Kimberly Fontan - Executive VP & CFO
Conference Call Participants
Shahriar Pourreza - Wells Fargo Securities, LLC, Research Division
Jeremy Tonet - JPMorgan Chase & Co, Research Division
Paul Zimbardo - Jefferies LLC, Research Division
Richard Sunderland - Truist Securities, Inc., Research Division
Andrew Weisel - Scotiabank Global Banking and Markets, Research Division
Stephen D’Ambrisi - RBC Capital Markets, Research Division
Presentation
Operator
Thank you for standing by. My name is Greg, and I will be your conference operator today. At this time, I would like to welcome everyone to today's Entergy Corporation Second Quarter Earnings Call and Teleconference. [Operator Instructions] And I will now turn the call over to Liz Hunter, Vice President of Investor Relations for Entergy Corporation. Liz, you have the floor.
Liz Hunter
Vice President of Investor Relations
Good morning. Thank you, Greg, and thanks to everyone for joining this morning. We will begin today with comments from Entergy's Chair and CEO, Drew Marsh; and then Kimberly Fontan, our CFO, will review results.
In today's call, management will make certain forward-looking statements. Actual results could differ materially from these forward-looking statements due to a number of factors, which are set forth in our earnings release, our slide presentation and our SEC filings. Entergy does not assume any obligation to update these forward-looking statements. Management will also discuss non-GAAP financial information. Reconciliations to the applicable GAAP measures are included in today's press release and slide presentation, both of which can be found on the Investor Relations section of our website.
CVR Energy oznámila za čtvrtletí zisk 0,34 USD na akcii a tržby 2,74 miliardy USD, obojí nad odhady. Loni ve stejném období měla ztrátu 0,23 USD na akcii.
CVR Energy (CVI - Free Report) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to a loss of $0.23 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +88.89%. A quarter ago, it was expected that this diversified holding company would post a loss of $0.54 per share when it actually produced a loss of $1.24, delivering a surprise of -129.63%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
CVR, which belongs to the Zacks Oil and Gas - Refining and Marketing industry, posted revenues of $2.74 billion for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 26.33%. This compares to year-ago revenues of $1.76 billion. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
CVR shares have added about 32.6% since the beginning of the year versus the S&P 500's gain of 8.5%.
What's Next for CVR?While CVR has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for CVR was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.61 on $2.02 billion in revenues for the coming quarter and -$0.22 on $8.06 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Oil and Gas - Refining and Marketing is currently in the top 8% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, Phillips 66 (PSX - Free Report) , is yet to report results for the quarter ended June 2026. The results are expected to be released on August 5.
This oil refiner is expected to post quarterly earnings of $7.68 per share in its upcoming report, which represents a year-over-year change of +222.7%. The consensus EPS estimate for the quarter has been revised 25.5% higher over the last 30 days to the current level.
Phillips 66's revenues are expected to be $36.17 billion, up 7.9% from the year-ago quarter.
, /PRNewswire/ -- First Horizon Corporation (NYSE: FHN) ("First Horizon" or "the Company") announced today its 2026 company-run capital stress test results. The 2026 test showed that, under hypothetical severe economic and business downturns, First Horizon would maintain capital ratios well above regulatory-required minimums. These internally generated results, which utilized the 2026 Dodd-Frank Act Stress Test Severely Adverse Scenario published by the Federal Reserve on February 4, 2026, reflect continued strong risk discipline.
"First Horizon's 2026 stress test results reinforce the strength of our capital position and the resilience built into our business model," said Hope Dmuchowski, Chief Financial Officer. "Our ability to maintain a CET1 ratio of 9.3% and a loan loss rate less than half that of our peer median - even amid a scenario of severe recession and market stress - demonstrates the value of our diversified revenue streams and prudent risk culture. Through disciplined capital management and unwavering focus on our clients, we are well equipped to deliver on our commitments, sustain our dividend, and support economic opportunity in our communities, regardless of the environment."
The following table reflects the Company's actual and projected stressed capital ratios under the Federal Reserve's Severely Adverse Scenario compared to required regulatory minimums.
% Regulatory Ratio
Actual
Projected Stressed
Capital Ratios
Regulatory Capital
Ratios
4Q25
Minimum
Minimum
Common Equity Tier 1 Capital ratio
10.6 %
9.3 %
4.5 %
Tier 1 Risk-based Capital ratio
11.5 %
10.2 %
6.0 %
Total Risk-based Capital ratio
13.3 %
12.2 %
8.0 %
Tier 1 Leverage ratio
10.2 %
9.1 %
4.0 %
These results include a $0.17 quarterly common stock dividend throughout the nine-quarter scenario horizon.
First Horizon's loan portfolio stressed loss rate of 2.3% is significantly lower than the 6.7% loss rate from the Federal Reserve-published median DFAST result. FHN's lower loss rate benefits from its portfolio mix, including lower-loss loans to mortgage companies and limited exposure to higher-loss rate credit cards. Additionally, the Company's pre-provision net revenue as a percentage of total assets of 5.1% exceeded the peer median of 3.0%. FHN's stresses to pre-provision net revenue are buffered by its counter-cyclical businesses of fixed income, loans to mortgage companies, and mortgage.
For more information, please see First Horizon's 2026 stress test disclosure at https://ir.firsthorizon.com/fixed-income/stress-test-results/default.aspx.
About First Horizon
First Horizon Corporation (NYSE: FHN), with $84.4 billion in assets as of June 30, 2026, is a leading regional financial services company, dedicated to helping our clients, communities and associates unlock their full potential with capital and counsel. Headquartered in Memphis, TN, the banking subsidiary First Horizon Bank operates in 12 states concentrated in the southern U.S. The Company and its subsidiaries offer commercial, private banking, consumer, small business, wealth and trust management, retail brokerage, capital markets, fixed income, and mortgage banking services. First Horizon has been recognized as one of the nation's best employers by Fortune and Forbes magazines and a Top 10 Most Reputable U.S. Bank. More information is available at www.FirstHorizon.com.